Podcast appearances and mentions of Rick Simpson

Dr. Deb Muth 00:02What if I told you that before a single drop of chemotherapy goes into a cancer patient’s body, we can take a blood sample, grow their actual living cancer cells in a lab, and test 70 different drugs against those cells, all outside the patient’s body, to find out which ones actually work. And what if I told you that the conventional oncology doesn’t routinely use this test? Well, today we’re going to talk about why that matters and we’re going to go through and I’m going to share a story that is very personal to me. It’s about a 38 year old man with a rare complex cancer diagnosis and the precision testing that is helping to keep that cancer from progressing. Stay with me. This is one that is going to change how you think about cancer treatment. Dr. Deb Muth 01:05You guys can put a little ad right in here before we start the next segment here. Hey everybody, welcome back to Let’s Talk Wellness Now. I’m Dr. Deb and today we’re going deep. I mean really deep. It’s some of the most cutting edge cancer testing I have ever seen in clinical practice. Now, normally I don’t talk about cancer. And I would not be sharing this story if it was anyone other than my own family. I do have permission to share and talk about this publicly. So I want to do this. I want to make sure that I share this message. And he is giving his blessing to share this story because we both believe that it can save lives. So his name is Cameron. He’s 38 years old. And he is my son-in-law. And two years ago, he came to me with a small lymph node underneath his arm and a bullseye rash. So of course, being the lime literate person that I am, my first inclination was to say, yeah, this makes sense. You have an enlarged lymph node because you have this bullseye rash. You got bit by the tick. Let’s keep an eye on it. If it doesn’t go away, let me know. So Fast forward a year and a half later, he comes to me and says, mom, what do you think about this? This thing is getting a little bit larger. And I said, yeah, it’s a little larger. Not sure. Let’s keep an eye on it. He wasn’t feeling anything. All his labs looked okay. And then one day he was out chopping wood and he started getting numbness in that arm and he felt it again. And it had exploded in size. And so after some evaluation with my daughter and him, we decided to do a ultrasound. And we thought what was going to come back was a fatty tumor. It felt like one looks like one responded to one. He’s 38 years old. He’s healthy. There’s nothing in our mind that’s ever thinking the result that we’re going to get back. Dr. Deb Muth 03:28Is a possible lymphoma. Needless to say, we were shocked by that ultrasound result. And we go fast forward, we have the biopsy. I requested a total excisional biopsy. I was told by the oncologist that that was old school. They don’t do that that way anymore. And I need to stay out of this. I need to let the experts take care of this because that’s what they do best. And this came from a breast surgeon here in Wisconsin. And so I stepped back for a moment. I let him do his biopsy and what came back was adenocarcinoma of an unknown origin. Had we excised the entire lymph node, we would have had more tissue to work with. I think we could have gotten a better diagnosis. So over the course of the next two and a half, three months, we have some more imaging done. We have some more testing done. They send a pathology out to Mayo Clinic. And what continues to come back is this incongruent test results. If anybody’s ever had this, it’s extremely frustrating. One test shows lymphoma. Now it shows breast cancer. Then the next week it shows estrogen receptor HER2 positive breast cancer. Two weeks later, another test comes back and it says, no, it’s not HER2, it’s triple negative breast cancer. And now it looks like it’s out of the lymph nodes. Now it looks like it’s in the lymph nodes. And we do a PET scan and they can’t find cancer anywhere except in this axilla area. But now we find a lymph node on the right side. So it must have spread.Let’s go ahead and do a biopsy on that. And so they biopsy the right side and the right side comes back with nothing other than tattoo ink. Now, all of this is kind of crazy. I am not a cancer specialist. I want to start by saying that I am not a cancer specialist. What I am sharing today is from a mother-in-law’s perspective, from a medical detective’s perspective, I do know how to do research. I do know how to find answers. And so what I’m going to share with you Dr. Deb Muth 05:54Is totally my opinion and totally my experience. And I’m not telling anybody to do anything different than what their doctors are telling them to do. But I am telling you to ask questions. So I go deep down the rabbit hole and find out that Tattoo Ink can appear like metastatic cancer on a PET scan. And we all know everybody gets tattoos today. They’re all over everyone. And yet we’re not thinking about how this tattoo ink can cause problems for us down the road, not to mention that there are heavy metals in them and it’s a toxin and it’s creating an inflammatory process in your body that your body’s constantly trying to get rid of. So the surgeon says to us, well, yes, that’s normal that that lymph nodes inflamed. It’s normal that there’s tattoo ink in it. The body’s doing what it’s supposed to do. It’s trying to get rid of a toxin. Okay. I will agree with that, but My son-in-law is covered with tattoos everywhere. And why didn’t we mention the tattoo ink that was found in the left axilla? We are only mentioning it in the right axilla. So there’s a lot of controversy, a lot of confusion. Many of you would never know any of this because A, you either don’t look at your lab results. And if you do, you don’t understand what you’re looking at. And that creates a problem for us, right? You don’t know what questions to ask. So we go into the doctor and the doctor tells us you have cancer and we’re going to swoop you in. And in the next two weeks, you’re going to be doing chemotherapy and radiation. And six months from now, we’re going to be doing surgery and there’s no time for questions and you’re scared shitless and you’re just doing what you can to survive. And I get that. And I totally understand that. And I appreciate that. But I’m telling you that If that is your choice, that is your choice. But as you’re doing that, take the time to ask the right questions. When this happened to us, there was a lot of challenging things with the oncology team. Nobody bothered to allow them to be a partner in their care. They dictated their care, but didn’t allow them to be a partner. So, Dr. Deb Muth 08:17Here’s what most oncologists do when patients get a cancer diagnosis. They look at the tumor type, they look at the stage, they look up the NCC guidelines, the National Comprehensive Cancer Network, and they follow the algorithm. Now, I have an enormous respect for conventional oncology. I really do. Working with cancer is probably one of the hardest things in medicine that anyone can do. The advances in this field over the last 10 years have been remarkable. But here’s my issue. Standard treatment assumes your cancer is the same as the cancer in the clinical trial that created the guidelines. It’s assuming that you and your cancer are the exact same as everyone else. You are the unique fingerprint, not the cancer. And this is the problem because your cancer is unique, just as unique as if you had your fingerprint taken, the mutations driving your tumor, the drugs your cancer cells are sensitive to, the metabolic vulnerabilities of your cancer. These are all different from the person sitting next to you in the chemo suite that has the same triple negative breast cancer or HER2 positive breast cancer or prostate cancer or colon cancer that you have. So what do do about that? Well, in my world, in the integrative medicine world, we test precisely, intelligently with the tools that most oncologists have never heard of. Or if they have, they haven’t incorporated it into their treatment modality for a variety of reasons. Either it’s not acceptable by the organization that they work for, they don’t understand it, They’re not going to be able to change their protocol anyway because they have to follow the NCCN protocol. So they don’t do it or they use a portion of it and they don’t do anything outside the protocol. So today I want to cover three things with you, three tools that we used that I think every cancer patient should be asking for when they start treatment or wherever you are in treatment at this point. Dr. Deb Muth 10:44you need to have these tests done. I don’t have any affiliation with any of these companies. I don’t get paid to tell you any of this. So let me just start by saying that I understand the chemistry behind these and how important it is to give you precision cancer treatment. And that’s why I’m talking about them today. The first one we’re going to talk about is the North Star response. This is your cancer surveillance score in the blood. How much cancer is circulating in the blood. The North Star Select, your cancer’s genomic blueprint from a blood draw. And the Datar Cancer Genetic Chemoscale, the live cell drug sensitivity test that tells us which drugs actually kill your cancer. So let’s go. Let’s dive into this. Let me just take a drink here. I’m going to cough a little bit. I apologize. I have this horrible tickle. It just never seems to go away, but that is not for today to discuss. So what is all of this? OK, the North Star response is a test that was developed by a company called Billion to One. And yes, that name is intentional because of the precision involved. It’s a next generation sequencing test, meaning it reads DNA at an incredibly detailed level. And it looks at something called methylated circulating tumor DNA or methylated CT DNA. Now let me break this down in plain English for you, because this can get a little overwhelming. When the cancer cells die or shed, they release tiny fragments of DNA into your bloodstream. We call this cell-free DNA or CFDNA, and it’s hidden within that cell-free DNA. And there are fragments that come from tumor cells. We call those CT DNA or circulating tumor DNA. Here’s what makes North Star’s response different. Rather than just looking for mutations in that tumor DNA, which is what most liquid biopsies do, and a liquid biopsy is just a blood test, Dr. Deb Muth 13:03This test looks at something called methylation patterns. Think of methylation like a dimmer switch on a gene. In healthy cells, certain genes are switched on and off in a very predictable way. In cancer cells, those dimmer switches go haywire. And cancer DNA has a characteristic hypermethylation, meaning switches are turning on and should be off or off and they should be on. And these patterns are essentially a cancer fingerprint in the blood. Now the North Star response scans more than 2000 locations in the genome for these cancer specific methylation patterns. And then it adds them all up into a single number called the tumor methylation score or TMS. So for Cameron, Cameron’s blood which was drawn on April 20th, 2026, his baseline tumor methylation score came back at 13. Now here’s the critical thing, to understand this was his baseline test, his starting point. And the real power of this test is in serial monitoring, meaning we run it again and again and again over time. And if that number goes up, the cancer activity is likely increasing. If it goes down, we’re likely suppressing the tumor activity. And if it stays flat or falls, that’s telling us that the disease is responding. So this is now in the blood. We have an actual fingerprint and every test from here forward will be compared to this number. Now let’s talk a little bit about this because I was not familiar with this test at all. I wasn’t sure what to expect. I wasn’t sure what to do with it. I did not order this test. He’s working with Inveda Medical and they are fabulous over there. I will tell you that from the beginning. This is coming from a practitioner and from a mother-in-law. They were absolutely wonderful to us. So when I saw this North Star, I didn’t know, should it be zero? Should it be a hundred? And when I talked to the doctor, he said, Dr. Deb Muth 15:29This number is actually really good. An average person walking around who’s never been diagnosed with cancer, who doesn’t have cancer, their number will be between 75 and 100. Cameron’s was 13. I think that’s fantastic. But what was the first question that went through my head? It’s probably the same question that you guys are doing. How can he have cancer with a number of 13 when it’s less than the normal average? And if we’re supposed to use this to track what’s happening with his cancer, how are we going to do that once we remove the cancer? Is this number going to go to zero? And it could possibly do that. And we may not be able to use this to track whether or not the disease is actually gone. But what we can do is use this to track over the course of his lifetime to see if the cancer cells are coming back long before we detect them on imaging. And that’s the huge part of this.So this is not a test that just anybody should go out and get because you’re worried about cancer. It is a test that should be done in somebody that is already diagnosed with cancer. So let’s start by making sure we explain that, okay? So imagine if every time your cancer cells are active and they’re shedding and they’re multiplying and they’re fighting back, they’re leaving a signature in your blood not just any signature, but a specific chemical tag that says, cancer’s here. That’s what the North Star Response Test reads. Those tags across thousands of locations and gives us a single score. So we track that score over time like a thermometer for your tumor. If it goes up, we get concerned. If it stays stable or goes down, we celebrate. And we can catch a change in the blood often months before it will show up on a scan. Pretty important when we’re talking about surveilling somebody for cancer returning, when we’re worried about it, and everybody knows the cancer patient is always worried after they get that clean bill health that something’s gonna come back, and most of the time they’re told that there is no way for them to determine that or know that from a blood test. And here is the blood test that can tell us, yes, it can. Dr. Deb Muth 17:51So I would really encourage you guys to talk to your oncologist about this. If you can’t find an oncologist that will do this, talk to an integrative cancer doctor. They will most likely be familiar with it. If not, ask them to find it for you and order it for you. So next, let’s talk about that genetic blueprint because North Star Select is a different test also by billion to one run on the same blood draw, but this one is doing something completely different. This is a comprehensive genomic liquid biopsy. Liquid biopsy just means blood tusks, meaning it’s looking for specific mutations in 84 cancer related genes, all from a blood sample, no biopsy needle, no surgery, just a blood draw. It looks for CNVS, single nucleotide variants, tiny one-letter typos in the DNA code. It looks for indels, small insertions or deletions in the DNA. It looks for copy number changes, the sections of the genomes that are duplicated or deleted. It looks at fusions. So when two genes incorrectly link together to create a dangerous hybrid, MSI status, micro satellite instability, which tells us whether immunotherapy is likely to work. And it has extraordinary sensitivity. It can detect a mutation that represents as little as 0.15 % of cell free DNA in the bloodstream. That is an almost impossibly small signal in the ocean of genetic noise. So what did this show for Cameron? This is where Cameron’s case gets clinically fascinating and where it tells the story of how his cancer is being held in check. Two major mutations were identified as actionable. One was called CRAS G12C. Dr. Deb Muth 20:11And it’s a variant-ELI fraction at 0.1%. Now, CRAS, if you’ve spent any time in integrative oncology, you’ve heard this name. CRAS is one of the most well-known oncogenes in cancer biology. Think of it like an accelerator pedal in the car. In a healthy cell, CRAS pushes the cell to grow when it receives the signal to do so. And then it stops. In cancer, crass gets stuck in the go position, like on the accelerator, foot on the accelerator, to the floor, going as fast as you can around that track, right? But it’s stuck there permanently. It doesn’t turn off and it’s supposed to be turning off. The G12C variant specifically is a mutation at a very precise location. Position 12 of the CRAS protein, where a glycine is replaced by cysteine. And this matters because CRAS G12C is now a drugable target. There are FDA approved drugs specifically designed to lock this mutation into its inactive state, essentially putting a foot on the brake. Now those are drugs like, and I’m gonna slaughter these names, Sordisib, a brand name is Lumacras, and Atacras, the brand name is Crastol. Neither is yet FDA approved for breast cancer, but they are approved for lung and colorectal cancer with CrasG2C. And Cameron’s tests identified 10 active clinical trials within a region that he could potentially qualify for with this mutation. The fact that his CRAS G12C is circulating at only 0.1%. That is a very low fraction. We call that a VAF, V-A-F, very low fraction. And it tells us something important. It means that this mutation is present in a small subclone of the tumor. It’s not the overall tumor burden. So either way, when we identify, we know it’s there. Dr. Deb Muth 22:37We can catch it and we can watch it. Now, here’s another interesting thing that we saw. His TP53 was at 0.23%. This is a tumor suppressor gene, the guardian of genome. And this gene is responsible for telling damaged cells to either repair themselves or self-destruct. And when it mutates as it is here in the position R196Q, that guardian goes off duty. The cell no longer has a reliable mechanism to prevent uncontrolled growth. So TP53 mutations are present in roughly 50 % of all human cancers. And there’s currently no FDA approved drug directly targeting the TP53 but there are clinical implications. TP53 mutant tumors may respond differently to chemotherapy and several investigational approaches, including TP53 vaccines and aurora kinase inhibitors are under active investigation. So we are seeing things happen in this part of cancer right now. Now there’s something called the VUS list and we are watching This is what we’re watching. beyond those two actionable mutations, NORSTAR Select identified what we call variants of an unknown significance, VUS, adenocarcinoma of an unknown significance, ACUP. These are mutations where we don’t yet have enough clinical evidence to determine whether they’re driving cancer or not, but we watch them. So on our mutation list was CDH1, a gene linked to hereditary gastric and lobular breast cancer, CDKN2A, a tumor suppressor cell cycle regulator, CDK12, involved in DNA repair, EGFR, ERBB, this is HER2 receptor, tyrosine kinases. Dr. Deb Muth 24:55I thought this one was pretty interesting since he had an IHC that showed a three plus HER2, but then when we confirmed it with FISH, FISH showed that was negative, but now we’re actually seeing genes expressing this HER2. So is there a HER2? Is there not a HER2? This is really important because if we don’t get these diagnoses right in cancer the first time, people will spend months and years treating the wrong type of cancer with the wrong type of medication. And this may be in part why some people do better than others. If we get it right out of the gate, they do good. If we don’t get it right out of the gate, they don’t do so good. Very important to have the actual genetic makeup of the tumor that’s growing in somebody. Now last, we have something called Notch C1, NRAS and RAF1. These are key pathway components. Now all of these were at very low baffs under 0.5%. These are just whispers, not shouts, but whispers that this cancer is excreting, but your body is listening. We have to be listening. We have to be able to watch these things and monitor these. Now here’s another note of clinical interest. It was an androgen receptor positive cancer. So also detected as a VUS.We know from tissue pathology that Cameron’s tumor was androgen receptor positive. So seeing this in circulation confirms that this AR expression of the cells are present in the bloodstream and that an anti-androgen approach remains worth considering. What that means is suppressing the testosterone. What all of you know I’m about ready to say is that I hate ever suppressing hormones, especially in a 38 year old male. That is not necessarily a good thing. So before we go suppressing hormones willy-nilly, we have to know that it’s the right thing to do. And we have to be able to combat all of the complications that are going to result of that. A 38-year-old male with no testosterone could lead to heart disease down the road, could lead to bone loss, could lead to dementia, Alzheimer’s. Not to mention the sexual side effects that are going to be present. And in a man that is very, very Dr. Deb Muth 27:20Difficult for someone to manage. So you have to be very specific and you want to be very, very diligent about what you’re doing in these cases like this. Now the MSI status was not detected. This tells us that cancer is not a microsatellite instability high, meaning that standard monotherapy may have a lower baseline response of probability and the strategic integration that we’re working with with in Vita could create an immunogenesis genicity becomes even more critical. So immunotherapy is going to be very critical in a cancer case like this and working with somebody that understands that and can carefully navigate that, especially if you have an autoimmune disease like Hashimoto’s or lupus, this is all very, very pristine and has to be looked at very carefully and done very diligently in order for somebody to do this without overstimulating that immune system and causing more problems. So when we looked at the blood and found this DNA fingerprint of the cancer cells circulating in the body, from that, what we see exactly is the genetic switches that are stuck on. They’re stuck on in the wrong position. This tells us which drugs were designed to fix exactly that problem. And it opens the door to clinical trials built for these specific mutations. It also gives us a list of things to watch for over time. And if one of those tiny little signals starts to grow, we know that cancer is gaining a ground in that area. And if it shrinks or disappears, we know we’re winning. This is like, I cannot tell you how exciting this is in the cancer world and the medical world because this is really pristine cancer therapy that we’re dealing with here. And to be able to have this is just so important to life saving events in treating cancer. So. Dr. Deb Muth 29:41Let’s talk about something called the Dittar Chemoscale. This is the battle before the battle. Okay, so I’ve saved the most remarkable test for last, and this is one from a company called Dittar Cancer Genetics. They’re based out of the UK. They are CAP and CLIA certified, which means it meets the rigorous standards required for clinical laboratory testing in the US. And this test is called the ChemoScale. And it is a live cell chemosensitivity assay. So let me explain exactly what that means because it sounds complex, but the concept is actually quite elegant. When we drew the blood from Cameron, the Dittar’s laboratory isolated what are called circulating tumor associated cells or CTACs. And these are actually living cancer cells and they’re associated cells that are traveling through his bloodstream. Excuse me. So let’s think about that for a moment. Real live cancer cells isolated from a blood draw. Those living cancer cells were placed into a lab environment and exposed to over 70 different drugs, both conventional chemotherapy agents and what we call repurposed drugs. I’ll talk more about those in a minute. The lab then measured how many of those cancer cells were killed by each drug expressed as a percentage of cell death. So the scale runs from zero to a hundred and below 25%, that drug doesn’t work well against any type of cancer in that person. Might work great in somebody else, but in that particular person’s cancer that they have, it’s not gonna work so great. Anything that’s 25 to 50 % is intermediate and above 50 % is a high response. And that’s really where Dr. Deb Muth 31:43we want to be. We want to see anything higher than 50 % because that’s a great medication that can be used to kill the cancer. This is not a theoretical test. This is not based on tumor’s genetic sequence and the computer algorithm that predicts the drug response. This is a HIS actual tumor cell being killed or not being killed in real time. That is the difference. So in traditional chemotherapy, we have our protocols. If you have triple negative breast cancer, if you have HER2 positive breast cancer, if you have prostate cancer, if you have colon cancer, here’s the protocol that you’re going to use because that’s the type of cancer you have. That’s what’s been studied. Now, the problem is most of these cancers have mutated over time, especially depending on how long they’ve been in your body, because that’s what they do to try to survive. They have to change so they can survive because your immune system’s constantly trying to kill them. And so this is a really important thing. And if we don’t take an individual into response or into our thought process when we’re creating these protocols, we may give a drug that doesn’t work at all towards that cancer and you just wasted seven cycles of chemotherapy with a drug that never would have worked in the first place or had such low resistance to it that it’s now just created side effects for you but did nothing to the cancer. And then we pull out another drug and we try that. And then we pull out another drug and we try that. Instead of us knowing precisely what we can use and what we can do. And this goes for both the conventional world and the alternative world. In the alternative world of cancer, we use things like IV vitamin C and tumeric and lately ivermectin and fenbendazole and mendendazole and all kinds of other things. And if we are not truly aware that this is going to do anything, we could be wasting somebody’s time and money. So I love that this test is available. I want to walk you through a little bit about what Dr. Deb Muth 34:01we are what we saw in our case, because I think this can make a big impact on people to ask the right questions. So this particular blood test looked at several different drugs. Cameron had sensitivity from 44 % up to 61 % on different medications. Now he was really lucky. The three main drugs that they would use to treat his cancer he had greater than a 50 % response to. So that was great. However, the drugs that were recommended for him to use out of the gate had less than 50 % activity. So he would have had one drug that was really good, one drug that was not so good. And we don’t know what the outcome would have been, right? So I think this is such an incredible, incredible test to have done. This is critical friends. I’m telling you if his oncologist had chosen the two drugs based on the general guidelines for his tumor, his cells would have largely not survived. But because we ran this test, we know. So we know to avoid the drugs that won’t work and we focus on the firepower where it really counts. So I want to also talk about this repurposed drug result because this is where it gets integrated for us. Now, this section is what I want everyone in our community, our Let’s Talk Wellness community, our members to understand. This is where conventional medicine and integrative medicine intersect in a peer-reviewed clinical validated way. So the Dittar test looks at live cancer cells against what they call repurposed drugs, meaning pharmaceuticals and natural compounds that were developed for the purposes, for other purposes, like it could be an antibiotic, it could be an herbal medicine, it could be all kinds of things, vitamins, whatever. But they have demonstrated anti-cancer activity in research. And when we’re talking about integrative medicine, this is a lot of where we get Dr. Deb Muth 36:26The integrative protocols from because these particular drug compounds are known for having anti-cancer benefits. And so that’s how integrative protocols get developed. But again, it could be just like medication, like cancer drugs. If your body doesn’t have a susceptibility to it, then you’re using a product that’s not necessarily going to work. And we all know we cannot take everything that somebody recommends just simply because it has an anti-benefit to whatever it is we’re treating. There’s only so many supplements you can take. There’s only so many things you can do before you get burnt out on taking it. We call it supplement fatigue. And so we want to be very precise with what we’re doing and target this very specific area. So one of the things that showed up really, really well for our case was artemisium, sweet wormwood. It’s an anti-malarial drug that has very potent anti-cancer effects. Now I found this extremely interesting in Cameron’s case because he does have a positive tick-borne illness called Babesia. And this is one of the things that we use to treat Babesia. The other thing I think is very interesting in this case is we are studying how parasites affect cancer these days. And that’s how Ivermectin, Fenbendazole, and Menbendazole have all gotten thrown into the treatment of cancer. And so for this drug or this herb to be sensitive to this type of cancer is really intriguing to me in the world of parasites and how parasites are truly decreasing the body’s immune system and causing cancer to grow. Another thing that worked, showed up really well for him was Valprolac acid. It’s an anti-seizure drug with HDAC inhibitor properties, and this disrupts cancer cell gene expression. There was a soy formula that showed up really well. Naltrexone, you guys have heard me talk about low dose naltrexone, LDN. This actually stimulates an endogenous opioid immune response feeling, and this drug actually showed up really well. Dr. Deb Muth 38:49Something as simple as quercetin. It’s an anti-inflammatory. This is a crass inhibitor in some studies. So this is really important. I’m sure most of you have heard about the benefits of green tea and green tea also actually has anti-angiogenic or anti-cancer benefits to it. Hydroxychloroquine, very popular drug. It’s another anti-malarial drug. So again, now we have two anti-malarial drugs that are susceptible to this type of cancer. And on top of it, he has a positive babesia test. So just saying, you got to connect the dots sometimes. You got to think outside the box sometimes. Metformin is very well known as a anti-proliferative in cancer. We use it to suppress the sugar because sugar feeds cancer. Nobody should be eating sugar if they have cancer. So this one showed up as well. And then CBD, we all know of the benefits of THC, the Rick Simpson oil, and CBD can be tested to see if that is beneficial to a particular cancer cell. This is different than THC. THC works very differently in cancer. CBD is your healthy component of it. It’s the part of the marijuana plant that does not make you high. So very important here. So now let me be very clear, because I always try to be very clear. This is not FDA approved. I’m going to repeat that. This is not FDA approved. This test is a laboratory developed test, not FDA cleared. These results represent in vitro testing, meaning in a lab, not inside the human body. And the results can differ in what we call in vivo, inside the body. And this is why I always say work with a qualified clinician who can interpret these results in full clinical context. But here’s why this matters. We now have evidence, live evidence of a cancer cell that shows sensitivities to compounds that are accessible, relatively safe, and some of which he may already be using, which some of them we were. Dr. Deb Muth 41:13We were already using some of them, which made us sit back and say, this cancer has been in there for two years. If it’s a triple negative breast cancer, it’s supposed to be an aggressive breast cancer that should have spread to a different organ already after two years. It is not, it has stayed in one spot. Also interesting in this case is that there is no breast tumor that they could find anywhere. This was all confined to the axilla into the lymph node. So to have this growing for this period of time with such a small tumor marker number, that 13 that we talked about in the North Star test originally, and to see some mutations, there’s a lot of questions to this particular case. And there are lots of questions to everybody’s cancer case. They are not all straightforward cancer cases. So this is what’s important to understand this fingerprint of these cancer cells so that you can identify exactly, exactly what’s going on and treat it exactly the correct way. Super important. So this kind of information gives us the direction in an integrative protocol. It’s not guessing. This is not eat more tumor, I can hope for the best. This is personalized tumor specific precision guided integrative oncology. It is very precise. There are several countries, several clinics like this around the country that offer this type of therapy. If it’s something that you’re interested in doing, I would encourage you to look at in Vita Medical. Hope for Cancer is another great facility. There are several great facilities around the country. Like I said, that could put together an integrative approach for you if this is something that you are thinking about doing. If you’re looking for answers, if you’re in stage four or stage three and you are not getting the results that you want to get, you want to look at a different approach. You want to do a combo approach of integrative medicine and traditional medicine and alternative medicine. Dr. Deb Muth 43:37I think this is so important to look at and have experts on your team. You know, in our case, Cameron’s cancer is very complex. It’s genomically aggressive in its presentation, yet it’s not progressing to distant areas, which is so wonderful. And I want to be careful here. I can’t tell you with certainty that this is any one thing. Biology is complex. Cancer is adaptive. It’s trying to survive. That’s what it is supposed to do. It is changing its shape. It’s changing its genetic structure. It’s changing everything to try to survive and try to hide against your immune system. Now we are not even close to the finish line in our journey, but what I can tell you is that what the integrative precision approach has done that standard care alone might not do. I can tell you that today and I will share our journey along the way for any of you that are going through this that want to look at a different approach as well because I think it’s important to have this information. So first of all, we know the tumor’s fingerprint. North Star response gives us that TMS score. so we can track it over time. And if the cancer tries to gain ground, we’ll see it in the blood before a scan, we’ll show it. We know the cancer’s genetic vulnerability. We know how to handle the DNA now. We know the watch list of things to look for. And when those signals start to grow, we have a roadmap of how to address it next, how to change it. We know which drugs will automatically work against the tumor cells. We’re not guessing based on a tumor type. We tested the cells. We know how many drugs in the commercial world and in the repurposed world will and will not work. And this is going to guide the treatment protocol that we walk forward with. So we’re not giving him drugs that won’t work or have a low response. Dr. Deb Muth 45:55We’re avoiding them completely and that matters because every ineffective drug is a dose of toxicity with no benefit. There is no lie to this. Chemotherapeutic drugs are toxic. That’s how they kill the cells, but they kill the good cells and the bad cells. And if we can avoid using a drug that’s not going to work, that is so important. And then we’re layering in those repurposed and natural compounds with proven activity against specific cells. This is not complementary fluff. This is biologically active tumor tested precision medicine. Very, very important. So here is what I need you all to know and what I want you to walk away with today. If you or someone you love is facing a cancer diagnosis before treatment starts, before the first infusion goes in, I want you to ask these questions so quick. Go grab something to write with. Pause this if you need to, because this is really, really important for you to do that. And we’re going to take a break for just a second while you guys go and do that. We’re going to give you a word from our sponsor, and then we’re going to come back. And I’m going to give you the four questions that I want you to ask specifically of your medical team so that you have the answers and the ammunition that you need to work with. So we’ll be right back. Dr. Deb Muth 47:29All right, everybody, welcome back. I hope you got your pencil, your paper, your pen, your phone, whatever you’re going to take notes with because this is important. So I’m to give you four questions that I want you to ask your medical team before you get started. Question one, can we do a chemo sensitivity test before we choose a chemotherapy regime? Ask specifically about DATAR, D-A-T-A-R. cancer genetics, Oncostat Plus, or a similar functional chemosensitivity platform. Very, very important to ask those specific things. All right, question two. Can we do a comprehensive liquid biopsy to identify actionable mutations and monitor tumor burden? Ask about North Star Select, Billion to One, Guardian 360, or Foundation One Liquid CDX? I’m gonna say those for you one more time, because I said them kind of fast. North Star Select by Billion to One, Guardian 360 or Foundation One Liquid CDX? Okay, question three. Can we establish a baseline tumor methylation score, TMS, so we have a surveillance marker to track over time? and ask specifically about the North Star Response Test. All right, question four. Is there an integrative oncology center that can layer precision guided natural compounds alongside conventional treatment? Research institutes like Inveda Medical Center, CTA CA Integrative Medicine, or Hope for Cancer, these people are doing integrative medical miracles. Let me tell you, I have researched every one of them. I have spoken to each of them individually before we made our decision of who we were going to work with. They are all fantastic. You want to work with an integrative nurse practitioner who understands oncology. And if you’re working with an integrative practitioner, you want to ask them these same questions about this test so that you can get the best outcome. Dr. Deb Muth 49:56For what you’re dealing with. You are allowed to ask these questions. You are allowed to want more information from that protocol that was designed for the average patient. You’re not average and your cancer is not average either. And your care doesn’t have to be. You do not have to settle for the same thing that the person sitting next to you in the IV suite is dealing with when you both have different cancers excreting different genetic material. This is so incredibly important. want to make sure you understand precision medicine is what changes the lives for people every single day, every single day. So I started this episode by telling you about a 38 year old man with a cancer that baffled conventional medicine and integrative medicine, an occult primary that was not found complex genetic genomic profile, a presentation that in many hands might have resulted in a one size fits all treatment protocol and a prayer. And instead we ran the tests, we mapped the fingerprint, we watched the cells, we guided the protocol, and we are still fighting with precision, with data, with intelligence. This is what Let’s Talk Wellness is all about not giving up. This is what not accepting we don’t know as a final answer and demanding the level of scrutiny and personalization that every cancer patient deserves. So if this episode resonates with you, please share it because somewhere out there, there is a person who is about to get the wrong chemotherapy because no one ran the right test. And maybe, just maybe, that This episode will be the reason someone asks the right question at the right moment. If you’re going through something like this, you need a group, you need somebody to connect with, please join our free Facebook group called Seen At Last. It is where we support one another, we share this information, we share knowledge, and we help people for free support and ask the right questions. Dr. Deb Muth 52:23And if you’re inclined in your heart to pray, pray for Cameron, we could use every ounce of prayer. If you are in a position where you can help support this journey financially, we do have a fund going in free funder. I can post the link below. Every little bit helps. If you have $5, $500, it doesn’t matter. We’re raising money for this treatment. And along the way, I am documenting every step of what we’re going through so I can provide more episodes like this for you guys to share the outcome and share what our journey is like so that it can help the next person along. I really always believe that whatever happens to us happens to us because we’re meant to share it. That’s why I’ve shared my personal journey. I’m sharing his personal journey and we want to help other people. So until next time, I’m Dr. Deb. Keep asking questions, keep advocating, and never ever accept being unseen.The post Episode 274 – Stop Guessing on Chemotherapy: The Live Cell Test Most Doctors Miss first appeared on Let's Talk Wellness Now.

Neurodivergence and weed. Munchie remedies. Long term toking. The Entourage Effect. Drag a bean bag into the circle and kick back for Part 2 of Cannabinology with UCLA's Center for Cannabis and Cannabinoids director Dr. Ziva Cooper and Smith College cannabis anthropologist Dr. Caroline Melly. We'll probe the great mystery and misfortune of hyperemesis, the effect of THC on memory and neuroplasticity, why edibles sometimes send you to a distant galaxy, CBD and inflammation, the risks of psychosis, older vs. younger brains and cannabis, a guy named Rick Simpson, how much weed is the right amount of weed, and if any studies warrant further research. Heads up: they do.   Follow Dr. Cooper on Google Scholar   Visit the UCLA Center for Cannabis and Cannabinoids website   Follow Dr. Melly on Google Scholar A donation went to Last Prisoner Project More episode sources and links Other episodes you may enjoy:Psychedeliology (HALLUCINOGENS), Dolorology (PAIN), Mnemonology (MEMORY), Attention-Deficit Neuropsychology (ADHD), Molecular Neurobiology (BRAIN CHEMICALS), Addictionology (ADDICTION), Neuropathology (CONCUSSIONS), Neuropathoimmunology (MULTIPLE SCLEROSIS), Salugenology (WHY HUMANS REQUIRE HOBBIES), Obsessive-Compulsive Neurobiology (OCD), Quasithanatology (NEAR-DEATH EXPERIENCES), Oneirology (DREAMS) 400+ Ologies episodes sorted by topic Smologies (short, classroom-safe) episodes Sponsors of Ologies Transcripts and bleeped episodes Become a patron of Ologies for as little as a buck a month OlogiesMerch.com has hats, shirts, hoodies, totes! Follow Ologies onInstagram andBluesky Follow Alie Ward onInstagram andTikTok Editing by Mercedes Maitland ofMaitland Audio Productions andJake Chaffee Managing Director: Susan Hale Scheduling Producer: Noel Dilworth Transcripts by Aveline Malek Website byKelly R. Dwyer Theme song by Nick Thorburn Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Key Points  Cannabis Health Radio podcast interview with Robin Swan of Swan Apothecary, exploring cannabis medicine's evolution, therapeutic applications, and patient guidance. Over 20 years, cannabis shifted from stigmatized to mainstream medicine — doctors who once feared calling Robin now send referrals from around the world. Key breakthroughs were driven by public advocacy, Rick Simpson's 2005 film Run From The Cure, and social media amplifying real patient stories globally. Modern cannabis strains have been hybridized to reach 35–40% THC, far above the 16–20% of the 70s — Robin flagged this as harmful, as it diminishes the whole-plant profile. Spraying chemicals on high-THC crops is contributing to chronic illness in cannabis users, a growing concern in Western cultivation practices. THC (2 molecules) targets cancer cells via apoptosis, while the C-family — CBD, CBG, CBN, CBC (60+ molecules) — reduces inflammation, repairs the myelin sheath, and supports healing. For cancer treatment, Robin's 30,000-client experience points to 500–1,500 mg of THC daily for six to nine months as the effective therapeutic range, not the commonly cited 60g over 90 days. Rick Simpson's gram-a-day protocol was based on naphtha extraction (~90% THC yield), but a gram is a weight measure — cannabinoid content varies by plant material and extraction method, so not all cannabis oil is equal. Strains matter when smoking but become irrelevant in concentrates — multi-strain compounding creates a richer cannabinoid bouquet, and dispensary sativa/indica labels are driven by terpene profiles, not plant genetics. Suppository dosing allows patients to absorb high THC doses without psychoactive effects — it absorbs into the colon wall within 3 minutes but takes up to 6 hours to reach the bloodstream. Robin recommends combining a nightly suppository with an oral dose using a 4:1 THC-to-CBD ratio, while daytime low-THC oral formulas allow patients to function normally. Cannabis and immunotherapy cancel each other out — science shows they are contraindicated, with neither working effectively when used together. On diet, Robin has not seen a single client survive who pursued aggressive restriction protocols (fasting, juicing, 20+ supplements, enemas) — nurturing the body and eating whole, simple foods with fewer than 5 ingredients is the preferred approach. Family dynamics significantly impact outcomes — one patient stopped cannabis oil due to family pressure and died, while in other cases families push cannabis on unwilling patients; respecting patient autonomy is essential. Visit our website: CannabisHealthRadio.comFind high-quality cannabis and CBD + get free consultations at MyFitLife.net/cannabishealthDiscover products and get expert advice from Swan ApothecaryFollow us on Facebook.Follow us on Instagram.Find us on Rumble.Keep your privacy! Buy NixT420 Odor Remover Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

What do Neville Shoenmakers, Brownie Mary, Dennis Peron, Lawrence Ringo, and Rick Simpson have in common? Harry E. Rose. Today on the show, we welcome Harry Rose to share his life story and experience making medicine, healing others, and himself through the power of this sacred plant. Harry Rose is a Cannabis Industry Consultant, Cultivator, and Manufacturer currently holding 3 California state licenses in Humboldt County for legacy mixed light cultivation, Type 6 manufacturing, and distribution. Experience with the entire process from application to approval of annual licensing with state regulators BCC, CDPH, CDFA, and all local agencies. First group of medical cultivation licenses in California, as well as the first Type 6 manufacturing license. Helped to createguidelines for type 6 manufacturing licenses with the city of Eureka. Extensive knowledge of cultivation and genetics. Growing cannabis since 1985.

 Robb experienced extreme fatigue, weakness, and dangerous bleeding episodes due to his condition, which required him to take up to 16 different medications daily including high-dose steroids and undergo multiple blood transfusions.Medical treatments included experimental procedures and a splenectomy, but doctors eventually told Robb his options were running out and suggested either an expensive experimental drug costing $600 per week or radiation therapy.A young man from Robb's church suggested medical cannabis as a treatment option, which initially angered Robb who questioned how marijuana could help when scientists and doctors couldn't determine what was wrong with him.Research into cannabis led Robb to discover Rick Simpson's story, Dr. Rafael's work from Israel, and most importantly US Patent 6630507B1 which lists cannabinoids as antioxidants and neuroprotectants for autoimmune diseases.After the splenectomy failed to improve his condition, Robb obtained his medical cannabis certification in Michigan in 2008 and purchased his first gram of Rick Simpson oil for $80 from a compassion club.Initial dosing began with tiny amounts using a toothpick to extract small portions of the oil throughout the day, as Robb considered himself a lightweight when it came to THC effects.Lifestyle changes accompanied the cannabis treatment including adopting an organic diet, eliminating processed foods, and studying the immune system to understand how nutrition affects overall health.Within one week of starting cannabis oil treatment and detoxing from prescription medications, Robb returned to work after being unable to work for over a year and a half.Robb became a licensed caregiver in Michigan, growing cannabis for five patients and eventually operating a 24/7 drive-through dispensary in 2016 with an on-site MD for patient certifications.Partnership with Dr. Calasperius beginning in 2020 created a comprehensive treatment approach combining traditional medical examinations with customized cannabis formulations based on patient needs and tolerance levels.Success story involved treating a six-month-old baby named Anastasia who was experiencing 100 seizures daily, using only CBD, CBG, and CBN without THC to eliminate her need for toxic narcotics.Frustration remains with public misconceptions about cannabis despite extensive patent evidence and 17 years of safe processing and provision in Michigan without any lawsuits or liability cases.Educational efforts continue to promote cannabis in all forms including hemp hearts for nutrition, emphasizing that the plant can provide food, housing, clothing, energy, and medicine while encouraging people to think independently about their health.Current operations focus on community wellness through the website communitywellness.life, offering various cannabis products including infused honey from a third-generation wildflower honey farm. Visit our website: CannabisHealthRadio.comFind high-quality cannabis and CBD + get free consultations at MyFitLife.net/cannabishealthDiscover products and get expert advice from Swan ApothecaryFollow us on Facebook.Follow us on Instagram.Find us on Rumble.Keep your privacy! Buy NixT420 Odor Remover Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

 Sasha Carr was raised by her father alone after her mother left when she was a baby, creating a unique upbringing where a 20-year-old male raised a female child.Her father was raised in an abusive, emotionless household which influenced how he raised Sasha, training her not to show emotion and lacking compassion in their relationship.After her father died of colon cancer in 2016, Sasha entered a destructive cycle of binge eating and taking handfuls of Tylenol PM to sleep because she didn't know how to process emotions.When Sasha visited her primary care physician for depression and sleep issues, she rejected the prescribed antidepressants and sleeping pills, choosing to explore natural holistic approaches instead.Cannabis entered Sasha's life when someone offered her a joint, and it helped her express emotions comfortably for the first time, calming the internal storm and enabling her to connect with people.Cannabis helped soften the edges of pain rather than dull it, allowing Sasha to experience and work through negative emotions instead of hiding them.Sasha taught herself to decarboxylate cannabis and make edibles, Rick Simpson oil, and other products, later attending St. Louis University's Cannabis Science Program where much of the curriculum she had already self-taught.Since Sasha had no friends who used cannabis, she created a local Nashville Facebook group for cannabis users that grew so large she eventually sold it, building a community from scratch.Women between ages 35 and 50 are becoming primary cannabis users for emotional regulation and trauma healing, taking control of their mental health with natural alternatives.Cannabis serves as a spiritual ally and meditation enhancer for Sasha, helping shut down her brain and achieve the calmness that meditation provides.For people experiencing deep loss, Sasha emphasizes they are not alone and can find welcoming cannabis communities through simple searches, even on platforms like TikTok.Sasha's father, who worked as a psychiatric RN, told her he felt like "a legal drug pusher" rather than someone helping people, which gives meaning to her natural healing approach. Visit our website: CannabisHealthRadio.comFind high-quality cannabis and CBD + get free consultations at MyFitLife.net/cannabishealthDiscover products and get expert advice from Swan ApothecaryFollow us on Facebook.Follow us on Instagram.Find us on Rumble.Keep your privacy! Buy NixT420 Odor Remover Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Key PointsCraig identified his lymph nodes as the most difficult area to treat after the squamous cell carcinoma metastasized into his neck and spread rapidly through his body almost overnight.Black salve treatment was used successfully on two to three dozen skin cancers over several years, with one recurring lesion in the jawline requiring multiple treatments through the soft tissue.Craig's wife noticed a suspicious mole with irregular pattern and color changes, prompting her to urge him to seek medical attention despite his reluctance to visit doctors.Inspiration came from a friend named Mick from Port Lincoln who had laser skin cancer that progressed through multiple surgeries, chemotherapy, and radiation before doctors said they would remove his cheekbone and upper jaw as a final measure.Craig maintained a positive attitude throughout treatment, stating he was confident the natural protocols would work and never feared for his life, unlike many other cancer patients.Multiple lesions appeared simultaneously after waking one night with a line running from a head lesion down to his lymph nodes, creating a half golf ball-sized mass in his neck.Internal bloodroot capsules were taken as part of the treatment protocol, causing approximately 30 lesions to emerge on his back, arms, and legs all at once several weeks later.Rick Simpson oil was consumed at a dosage of two grams daily, taken as suppositories during daytime to maintain functionality and orally before bed mixed with coconut oil for better sleep.Family members expressed resistance and concern about the alternative treatment approach, with some calling him an idiot for thinking he knew better than doctors.Cannabis access in Australia has become easier through decriminalized status in some states and a government medicinal cannabis program, with much product imported from Canada.Comprehensive detox protocols included a clean organic vegan diet with no sugar, castor oil liver detox treatments, coffee enemas, heavy metal detox smoothies with cilantro, and Essiac tea.Craig's partner's 77-year-old mother was diagnosed with stage four lung cancer that had metastasized to her heart lining, with doctors stating there was nothing they could do.Treatment for the partner's mother included Rick Simpson oil mixed with frankincense and myrrh, plus the same vegan diet and detox protocols, along with Fenbendazole and Ivermectin.Eight weeks after starting alternative treatment, scans showed the partner's mother's stage four lung cancer was nearly all gone, with only small scar tissue remaining. Visit our website: CannabisHealthRadio.comFind high-quality cannabis and CBD + get free consultations at MyFitLife.net/cannabishealthDiscover products and get expert advice from Swan ApothecaryFollow us on Facebook.Follow us on Instagram.Find us on Rumble.Keep your privacy! Buy NixT420 Odor Remover Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Join Nat and new co-host Miss Cadabra of the hemp and mycology focused podcast, ⁠⁠⁠Smoke to Smoke⁠⁠⁠ for our newest season! This week we discuss the world of Rick Simpson Oil (RSO), a potent cannabis extract that has gained attention for its potential therapeutic benefits in the holistic health community. Learn about the origins of RSO, the extraction process, its unique properties, insights into the latest research, and more. If you like tangents, plus thoughtful ramblings, the coveted title of 'Munchie of The Week' (MoTW) and of course, a lot of laughs, then listen here. --- Miss Cadabera's podcast - ⁠⁠⁠Smoke to Smoke⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Check out Rick Simpson books on Amazon

In this powerful episode, we dive deep into Jay Jay O'Brien's incredible journey of overcoming cancer not once, but twice, with the help of cannabis. Jay Jay - a certified Cannabis Health Coach and Educator - shares her inspiring story and the pivotal role cannabis played in her battle against the disease. Jay Jay's story is a testament to the transformative power of cannabis when used intentionally and strategically.  From her initial diagnosis in 2019 to facing metastasis in her brain in 2023, Jay Jay details how she took control of her health and fought back with cannabis as her ally. We'll cover: how Jay Jay's personal and family history with cannabis laid the foundation for her exploration of its medicinal benefits. Jay Jay's introduction to cannabis as a powerful medicine and the life-changing revelation that followed. Her experience with Rick Simpson oil (FECO), a concentrated cannabis oil, and its rapid impact on alleviating her debilitating pain. The journey of self-discovery and spiritual awakening she experienced during her high-dose cannabis protocols. How Jay Jay navigated the medical landscape and her struggles with the lack of support and acknowledgment from traditional oncologists. the pivotal role of FECO in Jay Jay's cancer remission, including her use of a multi-cannabinoid approach for enhanced effectiveness. Get the latest insights on the evolving relationship between cannabis and cancer.

This episode we discover how CBG begins the cannabinoid process in cannabis, Snoop Dogg is not giving up smoking weed, the creator of RSO, Rick Simpson is facing some tough times, a petition to increase THC dosages in edibles, we wonder whether Napoleon's troops were too high to fight and speaking of high – we stop on Cultivar Corner for Kootenay Quantum's Crystal Caviar.Rick Simpson facing some strugglesSnoop Dogg not giving up weedKootenay Quantum CannabisCrystal CaviarPetition for dosage increaseCBG explainedNapoleon's troops

When is it appropriate to beat the piss out of Wolf Blitzer for stupid questions?Taylor Swift Really Helped Turn Things Around on Election Night!Rick Simpson pain relief and WHY your LOCAL LEADERS are assisting in the closing of Oklahoma family owned dispensary and farms!IF I WERE GOVERNOR!SPOILED BRATS COURT!Dear Stan letters

So, after the excitement of last week's Rugby World Cup Episode – this week we chat about a group of birds that in South Africa are not quite as colourful as the green and gold birds we spoke about last week. But still, this is a group of birds that many birders love and often produces some amazing twitches in our region – you might have guessed it, but we are chatting about waders. I have a chat to Rick Simpson all the way from the UK, who is one of the co-founders of Wader Quest. We chat about awesome waders from around the world, work being done to conserve them, and we find out about this weekend's Wader Conservation World Watch event. Visit our online store to get your birding related merchandise at great prices https://www.thebirdinglife.com/online-storeIntro and outro music by Tony ZA https://soundcloud.com/tonyofficialzaLinks from show:BirdLife South Africa https://www.birdlife.org.za/SANCCOB Adopt a Penguin https://adopt.sanccob.co.za/get-involved/adopt-a-penguin/Westerman's https://westermans.co.za/Wader Quest:Website https://www.waderquest.net/events/wader-conservation-world-watch/Email wcww@waderquest.net

It's Halloween and way back in the 90's the station I used to work for had this thing called the Howler. It was an out of control good time featuring 5000 people and a band and some beer. Actually a lot of beer. This week I got back together with my old afternoon friend Jake Daniels and we just riffed on all the good times we used to have on air. Our show was always a contrast to the noise going on around us. We didn't need too much else in a show other than admitting we were coming in with nothing and would finish the show with a joke. It's a good ay to do radio if you are interested in life.In this episode you will hear Jake's infamous story with Nazareth, how we enjoyed watching Nickelback's ascension into stardom, Woodstock '99 (Jake was there), How Jake still hates country music and Metallica, hates soccer but loves Wrexham, and he shares medical advice and the benefits of going vegan. (Jake is a fan of Rick Simpson's Oil... you can google the rest)Anyhow - we have only spoken a handful of times in the last 20 years but as it is with old friends - you pick up where you left off. There is a video version of the show here - this was recorded live to video.Back in 2018, I had Jake on the show for an epic - Episode 100. Check it out here. Jake also mention he is looking for radio and broadcast work in Edmonton. You can contact him here. A transcription of this episode can be found here.Thanks to the following organizations for supporting the show:Blurve: A great way to help you prep your Show.Megatrax - Licensed Music for your radio station or podcast production company.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

watch your volume on this sermon, We did the best. we could with the audio. The volume will increase significantly at times.

Swim technique with Rick Simpson

*Warning: Lots of food talk and descriptions in this episode, make sure you grab a snack before listening.* Welcome back! We're talking about a summer full of dope Pacific Islander festivals up the West Coast with the recent Pacific Feats Fest in San Jose, and the upcoming 4 Days of Aloha (7/20-23) in Vancouver, WA and The PolyFest (8/5) in Auburn, WA. Speaking of travelling to Seattle-area, Forest and Mike break down their long-distance driving secrets (speeding, “find your rabbit”). This week's convo flows across many topics, including an upcoming trip to Hawaii, how to hit a baseball, selling ice cakes in Samoa, commissioning professional feet pictures, Britney Spears being struck by Spurs security, the entertainment and effects of Reality TV, and food scarcity in America. #1! We close with our shout outs to Modesto's Via Dolorosa Church for their Saturday Food Bank, Wardell Curry Sr., 7/10 and all the Dabbers, Rick Simpson and RSOs, homies who pick you up to go out, Miss Nude Oregon winner Tokyo, Devin K's bday, Talanoa Smith, Our Panel, Le Vasa Island Apparel, Big Bro Va'a Hosea, PasifikaByDesign, Island Mogul, Island Block, people in the service industry, Sami Jobes for being the world's best Mom and partner, and Our Listeners. No shout outs to the people who thought we were working as bouncers when we went downtown last week lol. Recorded 7/10/2023, Zoom. Sponsored by www.levasaislandapparel.com.

Many of those who were ordained at Petertide will soon be embarking upon title curacies. What makes for a successful curacy? What are some of the problems that can arise between curate and training incumbent, and how can they be resolved? The Archdeacon of Auckland, the Ven. Rick Simpson, was the IME Officer, working with assistant curates and training incumbents, for Durham and Newcastle dioceses for 11 years. On the podcast this week, he draws on his extensive experience to explain how title curacies can work best. He has written about this for the Petertide edition of the Church Times. Read the article here: https://www.churchtimes.co.uk/articles/2023/7-july/features/features/title-curacy-where-are-the-rocks-and-how-do-you-steer-round-them The second edition of his booklet Supervising a Curate: A short guide to a complex task (P173), was published in March by Grove Books: https://grovebooks.co.uk/products/p-173-supervising-a-curate-a-short-guide-to-a-complex-task Try 10 issues of the Church Times for £10 or get two months access to our website and apps, also for £10. Go to churchtimes.co.uk/new-reader

Welcome to another Home Grow TV Talk Show and Podcast - this week we sit down with Mickey from Elevated Cannabis.Elevated Cannabis is a licensed patient and caregiver for Crohn's and Chronic painElevated Cannabis IG: https://instagram.com/elevated_cannabis?igshid=MzRlODBiNWFlZA==Elevated Exotics IG: https://instagram.com/elevated_exotics_?igshid=MzRlODBiNWFlZA==Special thanks to AC Infinity for making this podcast possibleUse discount code "homegrowtv" on website and code "homegrowtv10" on amazonAffiliate Link: https://acinfinity.com/?ref=homegrowtvNEW IONFRAME EVO Series LED's: https://acinfinity.com/commercial-grow-lights/?ref=homegrowtvTopics Covered in Podcast:- Potent and Powerful strains for chronic pain- Favourite Breeders for patients and caregivers- Edible doses and mg amount- Rick Simpson oil or "RSO" - Breeding your first strains- Grow set up and gear- Copy Cat Genetix trains- Top 3 tips for indoor growingmuch more!Timestamps:0:00 - Intro1:50 - Elevated Cannabis Intro4:35 - Why did he start his first grow?7:18 - What are your favorite strains to grow?16:55 - What does it mean to be a Licensed Caregiver?19:48 - Edibles vs. Extracts vs. Flower27:33 - Let's talk Edibles!!35:36 - What's your grow set up and gear?38:48 - How do you pheno-hunt?42:28 - Tell us about breeding at Elevated Exotics48:35 - Some of your favorite breeders?50:20 - Top 3 tips for indoor growers?54:30 - How to Defoliate the Elevated way1:00:56 - where to find more about Elevated Cannabis Online1:02:08 - Thanks for watching

S1 E14: Rick Simpson's KID A with Matt Stronge You can try the best you can, you can try the best you can, but could you recognise a jazz reinterpretation of a song off Kid A if you didn't have the album's chronology pointing the way? Producer, photographer and general sidepig-in-chief Matt Stronge reckons he could, and this isn't even a band he knows a lot about! So please laugh until your head comes off at our cultured if confusing night out, and the various dubious tangents/texts/trips covered in its retelling. This IS happening! We ARE here! Enjoy/review/subscribe! The Extra Swill playlist: https://open.spotify.com/playlist/45NNtgh2FbvR4emjWbAVQh Emails and recommendations in the usual places - gigpigspodcast@gmail.com Follow us! @ivo_graham @alexkealy A 'Keep It Light Media' Production  Sales, advertising, and general enquiries: hello@keepitlightmedia.com Learn more about your ad choices. Visit podcastchoices.com/adchoices

Rick Simpson oil is for real folks and it's produced RIGHT HERE IN HENRYETTA! Non Addictive Highly Effective Pain Treatment Politicians Don't Want You to Know About!When chokeholds are simply NOT appropriate!Afghanistan exit and Title 42! BOTH pre-meditated chaosSupermarket infringes on customers right to free speech on their own cake!Autism man gets fired from grocery store!DEAR STAN LETTERS!!!! Get a letter to me @ Jokeman Productions LLC facebookWould you enjoy working for Britney Spears for free? ME TOO!!!

Interview Starts at 43:55   Kris Barrett is back for a magical chat about making his own Tarot deck. Stories from the Door Yard, Grinnanbarrettao Tarot and Oracle. We talk about how he bacame magical again after listening to our old Rick Simpson episode (see link below), and getting back into plant medicine and shamanis, and then of course dabbling in Chaos and Ceremonial, Hermeticism etc. How do art and magic fit, which one comes first are the inextricably intertwined through the whole process?   We also chat about Yates and Crowley, The Golden Dawn, magical principles, the hanged man, Stories from the Door Yard, D&D, Living by Magic, Tree of Life, Western Magic, and shaping Reality. Get signed up to his kickstarter or Patreon!   https://www.kickstarter.com/profile/grinnanbarrettao (Starts on 24th)   Patreon.com/kwbarrett   Kwbarrett.net   In the intro we chat about Darren's over the border rifle purchase, getting his truck ripped apart. Some emails from a couple listeners, and about our upcoming trip to Utah.   Links to stuff we chatted about during the show and the intro:   https://grimerica.ca/2015/10/16/139/ Rick Simpson Ep   https://grimerica.ca/2020/06/25/426-kris-barrett/   Help support the show, because we can't do it without ya. If you value this content with 0 ads, 0 sponsorships, 0 breaks, 0 portals and links to corporate websites, please assist. Many hours of unlimited content for free. Thanks for listening!!   Support the show directly: http://www.grimerica.ca/support https://www.patreon.com/grimerica   http://www.grimericaoutlawed.ca/support www.Rokfin.com/Grimerica   Check out our next trip/conference/meetup - Contact at the Cabin www.contactatthecabin.com Our audio book page: www.adultbrain.ca Adultbrain Audiobook YouTube Channel: https://www.youtube.com/@adultbrainaudiobookpublishing Grimerica Media YouTube Channel: https://www.youtube.com/@grimerica/featured Darren's book www.acanadianshame.ca   Join the chat / hangout with a bunch of fellow Grimericans  Https://t.me.grimerica www.grimerica.ca/chats https://discord.gg/qfrHVvP3 Get your Magic Mushrooms delivered from: Champignon Magique  Mushroom Spores, Spore Syringes, Best Spore Syringes,Grow Mushrooms Spores Lab Buy DMT Canada   Other affiliated shows: https://grimericaoutlawed.ca/The newer controversial Grimerica Outlawed Grimerica Show https://www.13questionspodcast.com/ Our New Podcast - 13 Questions   Leave a review on iTunes and/or Stitcher: https://itunes.apple.com/ca/podcast/grimerica-outlawed http://www.stitcher.com/podcast/grimerica-outlawed   Sign up for our newsletter http://www.grimerica.ca/news 1-403-702-6083 Call and leave a voice mail or send us a text   SPAM Graham = and send him your synchronicities, feedback, strange experiences and psychedelic trip reports!! graham@grimerica.com   InstaGRAM https://www.instagram.com/the_grimerica_show_podcast/  Tweet Darren https://twitter.com/Grimerica   Connect through other platforms: https://www.reddit.com/r/grimerica/  https://gab.ai/Grimerica    Purchase swag, with partial proceeds donated to the show www.grimerica.ca/swag   Send us a postcard or letter http://www.grimerica.ca/contact/ ART Napolean Duheme's site http://www.lostbreadcomic.com/  MUSIC Felix's Site sirfelix.bandcamp.com - The Rhythm of the Algorithm  Tabalusa - Broke for Free

Diagnosed with cancer, Mandy turns to Rick Simpson's THC oil recipe.

Bond Campmeeting 2022

This month marks the 10th anniversary of co-host Corrie Yelland being officially declared cancer-free after being given 2 to 4 months to live with anal canal cancer. She refused radiation because of the horrendous side effects. Luckily, fate intervened when her sister got her to watch the Rick Simpson video "Run from the Cure" and, with the help of friends, she started taking cannabis oil. When she got the "all clear" diagnosis 10 years ago, she dedicated her life to helping others. This podcast is a must listen to hear the story of this remarkable woman. 

Welcome to the latest Courtney Pine Global Podcast Bitesize Edition!  A coffee break's worth of cool jazzy vibes to wet your appetite for the full show.  Commercial free, and hand-picked by Courtney for a vibrant, and soulful listen!  This week amazing sax soloing from Leo Richardson, summer soft groovin' from Reuben James and NYC's best swingin us hard to the end courtesy of Steve Davis!  This music is ALWAYS the answer folks and it's happenin here, every single week!1.  Leo Richardson – Move 7'06Music Aid for Ukraine UBUNTU  Tr9Leo Richardson tr Rick Simpson pno Tim Thornton bs Ed Richardson drL Richardson, T Thornton, E Richardson/UbuntuRising star Leo channeling Coltrane on some modal grooves - more fantastic music from Ubuntu's Music Aid for Ukraine - please support this important cause!  2.  Reuben James - I Got What You Need 3'36Tunnel Vision RUFIO RECORDS Tr7Reuben James dr bs gtr fxs Gareth Lockrane fl Reuben James vox keys Ric Wilson vox Vanessa Butler bvsReuben JamesLush flute from Gareth Lockrane on this cool summer mix from Birmingham's own Reuben James!“I'd just got married, I was in a happy place and the whole thing was improvised in the moment...a lot of songs come from pain, but this one comes from a lot of joy. It was a big vibe for me. I was just in a moment of bliss.” 3.  Steve Davis – A Star for Chick 6'10Bluesthetic SMOKE SESSIONS Tr10Steve Davis tb Geoffrey Keezer pno Christian McBride bs Willie Jones III dr Peter Bernstein gtr Steve Nelson vbsDavisAmazing live jazz captured again by NYC's fab Smoke Sessions: check the incredible lineup, close your eyes and you're there!!One of the most acclaimed trombonists of his generation, Steve Davis has been a member of some of jazz's premiere ensembles: Art Blakey's Jazz Messengers, Chick Corea's Origins, the Jackie McLean Sextet, Benny Golson's New Jazztet, the Christian McBride Big Band, and the all-star collective One For All.  

Noah Hammond Tyrrell is a spiritual life & business coach. He is the CEO of Feel Good Hemp, the only hemp products company that offers a free self-empowerment platform and community to its clients. Noah is a yogi, coach and entrepreneur, and his mission is to help people feel good naturally while building a community of like-minded souls, dedicated to feeling good and doing good. ݆⁣

Today we are talking about the healing benefits of Cannabis. Yes, I said that right, Cannabis. Our speaker Ryan was so much fun to interview. He is so knowledgeable and an awesome person. We also go into Rick Simpson oil which is really interesting. LINKS & RESOURCESConnect w/ Ryan: https://www.instagram.com/therealryansprague/Ryan's Website: Connect with Cannabis by Highly OptimizedMy "Dark Shaman" Story on Ryan's Pod: Episode 58: Lessons In How to Protect Ourselves In The Psychedelic Space (feat. Sam Kabert)Order Kratom from Set & Setting: https://www.instagram.com/mysetandsetting/Rick Simpson Oil: Rick Simpson Oil (RSO) for Cancer: Does It Work?FREE "SoulChat" with Sam: Calendly.com/SamKabertGRAB MY FREE GUIDE: SoulSeekrz.com/TermsSchedule a FREE Chat w/ me: Calendly.com/SamKabertMy Book "SOUL/Life Balance": https://cutt.ly/hAydeYsMagicMind | https://cutt.ly/VRADrOH   use code "SoulSam" for 20% off!Wizard Teams (Virtual Teams For YOU Managed by US) | https://cutt.ly/xmVsYTe  Check out my Review of Pixar's "SOUL" Movie | https://cutt.ly/OmVsUNe  FREE Glossary of Spiritual Terms for the Newly Activated: https://soulseekrz.com/terms/ Wizard Websites - Learn to Build a Website w/ Virtual Assistants | https://bit.ly/3lCw2kU SHROOM BEACH Clothing | Use Promo Code "SoulSam" for 15% off with this link: https://cutt.ly/oItje42   Defiant Mushroom Coffee (Use "Sam15" for 15% OFF!) | https://defiantcoffee.co/  Permission to Podcast (Simply Show Up & Record): https://bit.ly/2N2NUoI  LET'S BE SOCIALJoin the journey — come hangout on social mediaInstagram | https://www.instagram.com/samkabert/ Join the Soul Seekr Facebook Group | https://buff.ly/2yi8ldA Twitter | https://twitter.com/soul_seekr_ LinkedIn | https://www.linkedin.com/in/kabert/  YouTube | https://buff.ly/3e4kXUO  ASK me ANYTHING: Email is Sam@CloneYourselfU.com and you can book a FREE business strategy call with me by going to Calendly.com/CLONE.Thank You,SamSupport the show

Bro. Rick Simpson

La portada de este número la ocupó el nuevo álbum del Claudio Scolari Project, Don't Know, recientemente publicado este 2022. Después escuchamos la re-lectura del icónico álbum de Radiohead, Kid A, realizada por el pianista y compositor londinense, Rick Simpson, en Everything All Of The Time: Kid A Revisited del 2020. En nuestra sección Clásico de la Semana hoy nos visitó el gran Larry Young y el legendario Into Somethin', publicado para Blue Note en 1965. Recibimos con los brazos abiertos en nuestra otra sección fija, Jazz en Español, al nuevo álbum del guitarrista Dani Pérez, Contrafacts, publicado a finales del 2021 para Underpool Records. También disfrutamos del Groove y el Jazz Rock de Garage A Trois o lo que es lo mismo; Charlie Hunter, Stanton Moore y Skerik, de los que escuchamos Calm Down Cologne, publicado en 2021. Y cerramos el programa de esta semana con el saxofonista neoyorkino Patrick Cornelius y Acadia: Way of the Cairns, publicado en el 2020. Que lo disfrutéis!

La portada de este número la ocupó el nuevo álbum del Claudio Scolari Project, Don't Know, recientemente publicado este 2022. Después escuchamos la re-lectura del icónico álbum de Radiohead, Kid A, realizada por el pianista y compositor londinense, Rick Simpson, en Everything All Of The Time: Kid A Revisited del 2020. En nuestra sección Clásico de la Semana hoy nos visitó el gran Larry Young y el legendario Into Somethin', publicado para Blue Note en 1965. Recibimos con los brazos abiertos en nuestra otra sección fija, Jazz en Español, al nuevo álbum del guitarrista Dani Pérez, Contrafacts, publicado a finales del 2021 para Underpool Records. También disfrutamos del Groove y el Jazz Rock de Garage A Trois o lo que es lo mismo; Charlie Hunter, Stanton Moore y Skerik, de los que escuchamos Calm Down Cologne, publicado en 2021. Y cerramos el programa de esta semana con el saxofonista neoyorkino Patrick Cornelius y Acadia: Way of the Cairns, publicado en el 2020. Que lo disfrutéis!

A discussion with Justin Riele and Rick Simpson about winning their age group at the Ironman St. George World Championships for 2021.

The guys sit down with Rick Simpson to discuss his start in racing street stocks, the various racetracks that have been around in Thunder Bay, Rick's new track called Thunder City Raceway, and more! Stay connected with Bench Racing Radio! Instagram: benchracingradio Twitter: @benchracingrad1 Facebook: Bench Racing Radio

How do you talk to patients about medicinal cannabis? Dr. Ashley Glode (University of Colorado) moderates a discussion on effectiveness and safety, misconceptions and more. Featuring Drs. Ilana Braun (Dana-Farber Cancer Institute), Daniel Bowles (University of Colorado), and Kent Hutchison (University of Colorado). Subscribe: Apple Podcasts, Google Podcasts | Additional resources: education.asco.org | Contact Us Air Date: 1/19/22   TRANSCRIPT ASHLEY GLODE: Hello, and welcome to ASCO Education's podcast on medical cannabis, also referred to as medical marijuana. My name is Ashley Glode, and I am an associate professor with the University of Colorado School of Pharmacy. It's my pleasure to introduce our three guest speakers Dr. Ilana Braun is chief of the division of adult psychosocial oncology at Dana-Farber Cancer Institute, and an assistant professor of psychiatry at Harvard Medical School. Dr. Daniel Bowles is an associate professor of Medical Oncology at the University of Colorado. We're also joined by Dr. Kent Hutchison, a professor of psychology and neuroscience at the University of Colorado Institute of Cognitive Science. Let's start with a simple but fundamental question. What is medical cannabis or medical marijuana? ILANA BRAUN: So Ashley, I think that's such a great first question. I think of medicinal cannabis as herbal nonpharmaceutical cannabis products that patients use for medicinal purposes. And typically they're recommended by a physician in compliance with state law. DANIEL BOWLES: Dr. Braun makes a really good point. And I think it's important to know when patients are referring to medical cannabis, there's a wide variety of different things they could be referring to. Sometimes they would be referring to smoked herbal products, but there are also edibles, tinctures, ointments, creams, all sorts of herbal-based products that people use and call medical cannabis. And then there are also the components that make up medical cannabis-- largely, the cannabinoids. And I think the big ones people think about are THC and CBD. And sometimes those are used in their own special way. So I think that it's important for us as providers to be able to ask our patients, what is it that you mean when you say, I'm using medical cannabis? ILANA BRAUN: I think that's such a great point. And I will add I think it's also important to remember that when you offer a medicinal cannabis card to a patient, you're giving them license in most states to access any number of products. It's not an insurmountable challenge, but it's a whole new world for traditional prescribers who are used to writing a prescription and defining what is the active ingredient, how often a patient will take the medicine, by what means. DANIEL BOWLES: I think the other thing we need to be very aware of, as hopefully people are listening to this across the country and elsewhere, is the laws vary wildly from jurisdiction to jurisdiction about what consists of medical cannabis, who is allowed to use it, and in what quantities. So I think it's really important that as we learn about these and we think about these, we think about how they apply to any of our specific situations in which we live in practice. KENT HUTCHISON: So it's interesting-- just follow up on what Dr. Braun and Dr. Bowles, what they're saying, those two words-- right-- medical and cannabis. I think the medical part is somewhat easier because it can refer to the reason the person is using. Are they using for medical reasons are they using for recreational reasons, even though that's a blur? But the cannabis part I think is what's really complicated. And this is what Dan was getting at. All the different products, all the different cannabinoids, I mean all the different bioactive terpenes and everything else in the material, all different forms of administration. That is where it gets super complicated to really define what that is. And then of course, there's so little research we don't really know what all those constituents do. ASHLEY GLODE: Now that we kind of have a little bit of familiarity with medical cannabis, can you comment on adult use cannabis and what that might mean for a patient? ILANA BRAUN: Ashley, I think it's a really good question. And in some of the early research I did to try to understand where medicinal ended and adult use began, or adult use ended and medicinal began, I began to discover a theme that emerged, which is they sort of blend into each other often. In other words, some of the oncologists that I spoke to believed that it was not such a bad thing for a patient with serious illness, and pain, and many other symptoms to have a sense of high or well-being. And conversely, when I spoke to patients using cannabis, sometimes a cancer patient used medicinal cannabis for enjoyment, and sometimes they used it for symptom management, and sometimes they used it for both. And so I think it is somewhat of a slippery slope between the two. Would you agree? DANIEL BOWLES: I think there are definitely blurred lines between the two. I think that the advantages of what most states would recognize as medicinal cannabis is usually they're less expensive, patients can use them in larger quantities. There are certain advantages. But there's also paperwork that goes along with medicinal cannabis that some patients don't feel comfortable with. Or particularly I think when you have a patient who's interested in trying cannabis or a cannabinoid for the first time, they might not want to go through all the extra steps required getting that medical marijuana card, whereas adult use, I think people feel more comfortable, at least in my state, sometimes walking into a dispensary to discuss the options with people who work at the dispensary and then get it from more of an adult use or recreational cannabis initially. And then if that's something that they find helpful for their symptom management, to then take those extra steps and try to get a medicinal card. ILANA BRAUN: I agree with Dr. Bowles that the target symptoms or the target effect is often similar and access can differ. KENT HUTCHISON: Yeah. Just to chime in, I agree. I agree also. It's definitely-- the lines get blurred. The recreational user might also appreciate-- for example, college students, I hear them say a lot of times that they appreciate some of the anxiety-reducing aspects-- right-- even though they're not necessarily a person who has an anxiety disorder. And then of course, patients appreciate a slight increase in euphoria or positive affect, and what does that mean? Is I mean they're also using for recreational reasons? Or is that completely, I guess, legitimate? On the other hand, there are sometimes I feel like when-- especially on the recreational side-- when people are using for the more psychological effects, the sort of psychotropic effects, I know sometimes the medical patients refer to that as being a little bit loopy as a side effect. So I feel like there's definitely some blurred lines. And maybe there are some places where we can think about in perhaps in a less blurred kind of way. ASHLEY GLODE: How often do you guys have a patient ask you about medical cannabis? And what are the most common questions they might have for you? ILANA BRAUN: In my psycho-oncology practice, patients frequently tell me they're using cannabis, often with good effect and minimal side effects for polysymptom management-- for instance to address nausea, or pain, or poor appetite, or sleep, or mood, or quality of life. But they don't ask me a lot of questions. For instance, one of my longest-standing patients. A man with metastatic cancer and gastroparesis. Vaporizes cannabis before meals to keep his weight up. And many of my patients also use cannabis as cancer-directed therapy. And for these patients, side effects can sometimes be more pronounced. For instance, I have a lovely patient with metastatic cancer who follows a Rick Simpson protocol. So what is that? That's an online recipe marketed with an antineoplastic claim. And so this patient targets hundreds milligrams of cannabinoids daily. And with such high cannabinoid doses, she sometimes feels spicy, or out of it, as she describes it. And then I had another patient who targeted high daily doses and developed a debilitating nausea and vomiting that was initially diagnosed as chemotherapy-induced nausea vomiting because it was so hard to tease out in the setting of so many medicinal agents, what was what. But the symptoms resolved completely within weeks of the cannabinoids being halted. And so as I mentioned, what's notable about all three of these patients, and many of the others I see, is that they are quite open with their oncology teams and me about their medicinal cannabis use. But they don't seem to rely me or other members of their oncology team for their therapeutic advice . We insert ourselves when we see potential harm, but much of the decision-making seems to be made-- I don't know in the naturopath's office, at the dispensary counter, or by trial and error. And this anecdotal experience in my practice is borne out in my research findings as well. Patients are just not getting the bulk of their cannabis therapeutics information from their medical teams. DANIEL BOWLES: In my clinical practice, I am asked about cannabis or cannabinoids a fair, amount often in the context that Dr. Braun is describing, where a patient is coming in and they're already using a cannabinoid or they are planning on doing it and they just want my opinion. And I think unlike talking about more conventional cancer-directed therapies where they really rely, I think, on their medical team for information and guidance, we are often more a supplement I think in terms of information. In terms of the patients who come to ask me about cannabis or let me know that they're using cannabis, it's a very wide selection of people. I see young people, old people talking about it, men, women, a variety of different malignancies. So there really is a lot of usage or are thought about usage of cannabis or cannabinoids amongst our cancer patients. I think if you look at the studies, they'll tell us that depending on where we're working, anywhere between 20% to 60% of patients have used cannabis in the last year to help manage some sort of cancer-related symptoms. And I think the other thing that is notable is you'll find people asking about cannabis or cannabinoids who I think we might not have otherwise expected. So for instance, Just this past week, I had a patient with anaplastic thyroid cancer in his 70s, and his daughter was wondering whether he could try CBD to help with his sleep and anxiety. She wanted to make sure that it wasn't going to interact with this cancer therapies. And I appreciated her bringing it up, and we could have a frank discussion about the pluses and minuses of it, just like we might any other therapeutic intervention. So I think that particularly as the laws have changed across the country, more and more people are willing to tell us that they're trying cannabinoids and cannabis than maybe would have even 10 or 15 years ago. KENT HUTCHISON: I think in an ideal world, patients would be talking a lot more with their physicians about this topic. And I think unfortunately that a lot of people do get their information from dispensaries. From the media, from social media, from their kids, and from whoever. And I think that's something that I hope will change in the future. DANIEL BOWLES: In terms of questions that I'm often asked, I'll be asked if it's going to interact with their cancer treatments, in terms of making their medications more or less effective. I do get questions about how I think their cannabis use might affect some of their symptoms. I get questions about other drug-drug interactions-- let's say, interactions with opiates, or benzodiazepines, or some of these other medications that a lot of our patients are on. ASHLEY GLODE: In a recent survey 80% of medical oncologists who discussed medical cannabis with their patients, 50% recommended it in the past year, but only 30% felt knowledgeable enough to make recommendations. What do you guys think needs to be done to address this knowledge gap? And what resources do clinicians have to get and stay informed? DANIEL BOWLES: So I'm a big fan of the NCI's PDQ as a great resource. It has a fairly objective information about cannabis and cancer specifically. So I think that's a nice reference for people who are interested in getting an initial overview on the topic. I think there are also a number of different educational programs. I know the University of Colorado, for instance, has a Cannabis Science Master's and also a certificate program. So there are courses available for people who want to educate themselves more on this topic. ILANA BRAUN: Yeah. I guess when I think about what needs to be done, I think that cannabis needs to become a routine part of medical training curricula and CME programs. I think that a federal funding for high-quality clinical trials and a loosening of federal restrictions on accessing study drug were to occur, that would be really a big boon for the medical community. And my colleagues on this podcast I know are doing some very creative pragmatic clinical trials naturalistic studying what is happening in the field. And I am doing clinical trials using an FDA-approved version of cannabinoids. But it's still very hard to study whole-plant cannabis in a form that is sort of a standardized trial drug in a cancer patient. And then when I think about where I would begin to read, I don't think there is a single source, unfortunately. But a great place to start reading is actually a project that Dr. Hutchinson was a part of, which was an expert panel that was assembled by the National Institute of Science Engineering and Medicine in 2017. And they produced a monograph on the health effects of cannabis and cannabinoids. And it's several hundred pages long, including sections devoted just to oncology. So in other words, there is scientific evidence to evaluate, and it's sizable. DANIEL BOWLES: The Austrian Center for Cannabinoid Clinical and Research Excellence also is a helpful resource. One of the nice things about that is they actually give some dosing suggestions or ideas for people who really don't quite know where to start. Right now, there aren't a lot of people in that position to say, here's how it should be done. Here's how it gets dosed. Here are the data to support those decisions. And so the folks in the next level of training don't learn it in the same way that we have learned how to prescribe other medications. And they can't then lay it down. So because the data are scant, in some respects, and particularly for herbal products that So. Many of our patients are using, I think it falls outside the medical model that we've all become so used to using to learn how to take care of patients. And I think that's one reason that so many oncology providers feel interested in learning more about this topic, but don't feel comfortable giving patients guidance on how to use them. KENT HUTCHISON: So both Dr. Braun and Dr. Bowles identified some of the key resources out there. And certainly the training issues that Dr. Bowles just talked about are important. And I do want to emphasize the one thing that Dr. Braun mentioned, which is basically that we do-- we lack research and we lack data on some key important issues, like dosing, for example. What dose is effective? So cannabidiol has been out there for a long time, but what dose is effective for what? We don't know, right? So we definitely lack research. And there are definitely obstacles to doing that research. ASHLEY GLODE: So you guys brought up some good points about there being a lack of data, but also there is some evidence. So what is the current research and evidence on the efficacy of medical cannabis for management of cancer symptoms and cancer pain, specifically? DANIEL BOWLES: So there was a really nice review article that just came out in the BMJ looking at cannabis and cannabinoids, not specific to cancer pain, but including cancer pain. And what they found-- they looked at different preparations from herbal products-- smoked herbal products, oral agents-- cannabinoids, more specifically. They found there is a modest, but a real improvement in pain in patients or research subjects treated with cannabinoids versus those usually typically treated with placebo. In particular, the data are supported in neuropathic pain, I'd say more so than the other pains. I think the data are less compelling with regards to many of the other symptoms that people often use cannabinoids for, such as sleep, anxiety, appetite, things along those lines. ILANA BRAUN: So I'll tell you a little bit about how I think about the evidence base in oncology for cannabis use. So I'll preface this with two points. The first is that, as I mentioned, cannabis products tend not to be one active ingredient, but hundreds of active ingredients-- cannabinoids, phenols, terpenes, they all have bioactivity. And they don't work individually, they work through complicated synergistic and inhibitory interactions that have been termed entourage effects. So I don't think one can easily extrapolate from clinical trials of, say, purified THC, to understand whole-plant cannabis' activity in the body and how it might perform in humans. And then the other point I'll make is that when I think about the types of clinical evidence that we as clinicians hold dearest, it's clinical trials of our agent of interest in our population of interest. So cancer patients using whole-plant full-spectrum cannabis that they would access at a dispensary or grow in their own home. With this in mind, I believe the strongest evidence, randomized double-blind placebo controlled trials of whole-plant cannabis and oncology populations begins to support its utility for chemotherapy-induced nausea and vomiting. So there have been a few studies that have looked at this. But just in 2020, the most recent is a study by Grimison, et al. It was a multicenter randomized double-blind placebo controlled crossover trial comparing cannabis extract. And I think the extract they use was a 1 to 1 THC to CBD ratio versus a placebo in patients with refractory chemotherapy-induced nausea and vomiting. And what they found was that with active drug, there was a complete response in 25% of participants versus only 14% with the placebo. And although a third of participants experienced additional side effects with the active drug-- so remember, this was a crossover trial, so they saw both arms-- 80% preferred cannabis to the placebo medication. So that's clinical trials of cannabis and cancer. But if we expand the base of the pyramid of acceptable evidence to include high-quality clinical trials for health conditions other than cancer and extrapolate back, then I agree fully with Dr. Bowles that there's a growing body of evidence that cannabis may be beneficial in pain management. And there have been many clinical trials done in this arena, and they span myriad pain syndromes, including diabetic neuropathy, post-surgical pain, MS pain, sickle cell pain. And so it does seem like cannabis works for pain management in several other illness models, so we could extrapolate back and hope that it works in cancer pain. And then there is a small body of evidence with nabiximols, which is a pharmaceutical that has a 1 to 1 THC to CBD ratio. And it's a sublingual metered dose spray. And it has been trialed for opioid-resistant cancer pain. And this is not as a single agent, but as an adjuvant to opioids. In early trials, two times as many participants in the active arm as compared to the placebo arm demonstrated a 30% pain reduction. And for the pain specialists who are listening, they will know that is a substantial pain reduction. But then, additional studies fail to meet primary endpoints. I think there were three clinical trials that followed. Nabiximols was found to be safe and effective by some secondary measures, but the FDA opted not to approve nabiximols for cancer pain. So I think there's some suggestion of effect, but there's some smoke, but no fire-- no pun intended. DANIEL BOWLES: I think many of the studies that have been done looking at cannabis-- or cannabinoids-- have been compared to placebo or they've been crossover. And I would say fairly consistently, there is some improvement in pain scores with the cannabis products versus placebo kind of across a wide variety of disease spectrums with regards to pain. I think one of the other questions that a lot of people have asked is, can you decrease people's opiate usage using cannabis? As we know, there's a huge epidemic of opiate misuse in the United States of America right now. And I think many people are looking for ways to decrease opiate usage. There was a nice study done from Minnesota in conjunction with the Minnesota dispensaries-- or state marijuana program-- where some researchers randomized people to starting kind of herbal cannabis products early in their study or three months into their study. So it was kind of a built-in control. And they looked at opiate usage rates, pain scores, quality of life scores, et cetera. What they found is there, again, was some improvement in pain control overall in the cannabis users. However, it did not equate to a decrease in opiate usage. So I think that it's an open question that I think a lot of people want to know the answers to before they start recommending or incorporating cannabis or cannabinoids more widely into their practice. KENT HUTCHISON: It's certainly a complicated issue, in some ways, right? Because the research which is summarized very nicely by both Dr. Braun and Dr. Bowles, it is suggested, but not overwhelming, by any stretch, right? It's not clear-cut. And I think that one of the big issues here we talked about the very beginning is how complicated this cannabis thing is. and Dr. Braun alluded to this also, that there are obviously many different formulations, many potentially active constituents in cannabis. And so what has mostly been studied so far is either synthetic versions of THC or nabiximols, which is probably the closest thing to what some people are using. So I think the jury's still out, for sure. And I think hopefully at some point, what will happen is that some of the products that are actually being used by people-- because most people aren't using nabiximols, most people are not using THC only, hopefully there'll be some trials of the things that people are actually using out there in the real world that will tell us something more about whether it's effective or not. And maybe even more specifically, which constituents-- which parts, together are most effective with respect to pain. DANIEL BOWLES: I think one of the other topics that some of my colleagues have alluded to already is not just cannabis' role in symptom management. I think pain is often what people think of, and people are using it for chemo-induced nausea and vomiting, anxiety, sleep, appetite, but a fair number of patients are also using cannabis or cannabinoids with the hopes that it is going to treat their cancer like a chemotherapy or an immunotherapy may. And oftentimes, patients will point to preclinical studies looking at oftentimes very high doses of THC or CBD that might show tumor cell death or tumor reduction in test tubes. And I spent a fair amount of time-- and I know some of my colleagues spent a fair amount of time-- talking with patients about how it's a big step between cannabis or cannabinoids working to slow cancer growth in a test tube, to working in an animal system, to working in people. ASHLEY GLODE: So what are the most important considerations clinicians should keep in mind before recommending medical cannabis to patients with cancer? DANIEL BOWLES: We should be asking why they want to use cannabinoids. I think just like we might any other medication that people are thinking about trying-- or herbal product that people are thinking about trying-- I think we need to ask why they're interested in using these products. So is it for symptom management? Is it for some of the ancillary side effects of cannabinoids or cannabis? Why are they wanting to use it? And I think trying to incorporate that more than into the medical model, I ask my patients, hey, if you're using this particular product, do you feel like it's doing what you intended it for it to do? If it is and it's legal in your state, great. Do it as you feel fit. If it's not meeting your goals, if it's not helping with the pain, or if it's not helping with the anxiety, or it's not helping with the nausea and vomiting, maybe we should rethink whether we would use it. Just as if I was prescribing more conventional anti-nausea medication and you didn't think it was working, we wouldn't keep using it. So I think that's a really important thing to keep in mind. I think the other thing to know from a safety standpoint is, who else is in the household? We have a psychiatrist on the call with us today. I think there is an ample amount of data that cannabis is not safe for young people. It's not safe for growing brains. And I think we need to make sure, just as we would want people's opiates to be secured, that their cannabinoids and cannabis products are secured as well, from those who do not want to use them. ILANA BRAUN: And the thing I would keep in mind is that in most states, giving patients a medicinal cannabis card is allowing them to access any number of products with different ratios of active ingredients, delivery mechanisms, onset of action, potencies. And if you don't discuss all of these issues with your patients, these are things that they will decide at the dispensary counter, or by discussing with friends and family, or by trial and error. And I think it's really important that we clinicians guide this narrative. ASHLEY GLODE: So what kinds of patients are not good candidates for medical cannabis? DANIEL BOWLES: I would not recommend medical cannabis for people who can't meet some of the criteria we already discussed. So people who can't keep it safe in their households or have concerns about diversion in their own households. Those are people who I think would not be great candidates for medicinal cannabis or cannabinoids. ILANA BRAUN: As the psychiatrist on the call, I would add that I worry for people with a strong history of psychosis, or currently psychotic, or with a strong family history of psychosis. And perhaps those severely immunocompromised, since there is evidence of fungal and mold contamination in some cannabis products. DANIEL BOWLES: The other group of people I discussed this with are patients on immunotherapies. One of the ways that cannabis may be effective in some of the symptoms we discussed is it's an anti-inflammatory agent. One of the ways it could be detrimental for patients on immunotherapies is that it's an anti-inflammatory agent. There is one small study that suggested that patients might have worse responses to immunotherapy who are cannabis users versus those who are not. So that is a conversation I like to have, just so patients feel like they can be informed. I think lastly, cannabis even for people with medical cards, is not free. So there can be a financial burden for people who are using it. So that's something that I'll often bring up with people as well. KENT HUTCHISON: One thing I would add to this would be history of a substance use disorder might also be a consideration here as well. Mainly because you don't know what the person is going to get, and it could be something that lends itself to relapse or encourages a problem. So I would add that to list. ILANA BRAUN: And I would second what Dr. Bowles said about the financial challenges of using cannabis regularly medicinally. It's not something that's covered by insurance, either. So these are out-of-pocket expenses, and they can add up fast, particularly for patients in the oncology space using it for antineoplastic therapy. ASHLEY GLODE: So is there a concern about drug-drug interactions for patients currently undergoing active cancer treatment? DANIEL BOWLES: There are some data that there can be drug-drug interactions with cannabis and certain agents. In particular, cannabidiol, or CBD, is a CYP3A4 inhibitor. And there are a lot of drugs that are metabolized through that particular system. So I think that that's the clinical relevance of those interactions, I think, is sometimes unknown. But that is another topic that I do think we need to make sure we bring up with our patients. ASHLEY GLODE: Thank you. Yeah. So a lot of what we'll do is from a drug interaction perspective, use the FDA-approved products that we have available to run through a drug interaction checker, like Dr. Bowles mentioned. So we'll use dronabinol as the THC-based product and epidiolex as the CBD-based product. There's also some resources, such as natural Medicines Database. And some of the pharmacy programs that we use, you can actually put in marijuana or cannabis as a drug and run drug interaction checks. So there's multiple potential interactions, like he mentioned, through the immune system. But through the cytochrome P450 pathway, cannabis has been shown in some instances to be an inhibitor, sometimes an inducer of certain enzymes, as well as a substrate. So it's really important to work with your pharmacy colleagues to run through different potential interactions that may be present. ILANA BRAUN: I'll just add one thing, just in case that's helpful. I mentioned earlier in the episode that I had a patient who used cannabis as an antineoplastic drug, and targeted very high doses and developed a terrible nausea and vomiting. And when she stopped, so did the nausea and vomiting, even though her chemotherapeutic continued. And I, to this day, don't know if that was a cyclic nausea and vomiting syndrome, which has been known to plague some heavy cannabis users, or whether drug-drug interactions led to her high-dose cannabis triggering high blood concentrations of her cancer-directed therapy at the time. And so I think that drug-drug interactions do need to be carefully weighed. ASHLEY GLODE: So wrapping up, has the medical community stance on medical marijuana shifted in recent years with legalization in many states? ILANA BRAUN: I don't think we know the answer to this, about how sentiment has shifted because there aren't longitudinal studies that I know of examining this question. But we need some. And one could imagine that as medicinal cannabis becomes are commonplace, providers are increasingly confronted with questions about how to guide care and the desire for high-quality clinical trials and in-depth cannabis therapeutics trainings increases-- and as one piece of evidence for this, at the end of 2020 the National Cancer Institute held a first-in-kind four-day conference at the intersection of cannabis and cancer. And so I'm hopeful that grant opportunities will follow from that. DANIEL BOWLES: I think overall there has been more willingness to discuss cannabis in the context of patient care in the last decade. A couple of ways that I see this is I much more frequently see cannabis use described not necessarily in the drug history, or in the social history, but in the medical history, or in their medications, if they're using it for medical or therapeutic purposes. I think the other place that I've noticed cannabis usage become a bit more mainstream is in the clinical trial setting-- not in clinical trials of cannabis, but one of the things that many of us do is clinical trials of new drugs. And very frequently, 10 years ago we ran into trouble trying to get our patients who were using cannabis products for cancer symptom control onto these clinical trials because of potential drug-drug interactions, or just the fear of the unknown. And I feel like we run into that less commonly now. KENT HUTCHISON: I think it's also worth pointing out that there have been more and more podcasts like this one, right? So to the credit of this organization, I think we are seeing some change. I just wanted to highlight that. And I compliment everyone here for putting us together and putting it out there. ASHLEY GLODE: All right. Well, thank you. That is all we have for today. And thank you very much Drs. Braun, Bowles, and Hutchison for a delightful conversation. Thank you so much to all the listeners tuning into this episode of the ASCO Education Podcast. [MUSIC PLAYING]   SPEAKER: Thank you for listening to this week's episode to make us part of your weekly routine, click Subscribe. Let us know what you think by leaving a review. For more information, visit elearning.asco.org. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care, and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.

[include file=get-in-itunes.html]Rick Simpson from Phoenix Tears joined our show to discuss how hemp oil can (I don't want to use the word cure) assist the body to reverse late stage diseases. Remember your body and God do all the heavy lifting. Substances like hemp oil only help the body do its own healing. Did you know that over 5,000 products can be made from this one plant? You can build homes with it, use it for paper, clothing, energy, concrete and most notably eliminate disease with it. The cancer industry alone is a 200 billion dollar a year industry. Can you see how this plant MUST be illegal? Rick Simpson is the creator of the documentary (linked to below) called Run From The Cure. He was all fired up for this show and I think you're going to love it. Rick explains why hemp oil is so beneficial for healing all kinds of diseases not just cancer. It's amazing that we cannot have access to this wonderfully healing plant that is a part of God's creation. He got fired up during this podcast and I can understand why. Governments around the world are purposefully demonizing this most powerful plant and as a result people are dying needlessly because they can't get access to the hemp plant. After you listen, comment below and tell us what you think! We discuss the following and so much more: How to make hemp oil What diseases hemp oil is most effective with Where to buy hemp seeds online How the government has raided his house and demonized him Rick's story about how he got involved with using hemp oil The 4 different ways to take in hemp oil And so much more! Can hemp oil really be the cure for all diseases then? - Click to tweet this! - Get Notified:[ois skin="Show Page2"] - Commercials: - Please Subscribe: Subscribe To Our Radio Show For Updates! - Other Shows:[include file=show-links.html] | All Shows With This Guest - Show Date:Wednesday 3/6/2013 - Show Guest:Rick Simpson - Guest Info:Rick Simpson has been working with hemp oil for many years. He used it after he was diagnosed with his own skin cancer and was able to get rid of it. He teaches people all over the world how to make hemp oil (not from the seed but from the bud/leaf of the plant) so that they can cure their own diseases. He's is the founder of an organization called Phoenix Tears which serves as the foundation for future projects involving the use of hemp oil. Read More... He is also the creator of the wildly popular documentary called Run From The Cure which educates people about not only the power of hemp oil as well as the many uses for it. He recently wrote his first book called The Rick Simpson Story which is available on his website www.phoenixtears.ca. - Topic:Hemp oil and disease - Guest Website(s): http://www.phoenixtears.ca http://www.phoenixtearsmovie.com/ Email: phoenixtearsadmin@gmail.com (Guest Social Links Below. Please Follow Them!) Facebook https://www.facebook.com/pages/Rick-Simpson/298774923502987 Twitter https://twitter.com/RickSimpson Youtube/Vimeo http://www.youtube.com/chrychek - Guest Product(s):Click Below To Checkout The Products While Listening! :) PhoenixTears: The Rick Simpson Story - Items Mentioned: Run From The Cure documentary by Rick Simpson Dr. Mark Sircus --> (Our interview with Dr. Sircus) Dr. Stanislaw Burzynski (Watch the movie here. See the movie site here.) Reefer Madness movie Dr. Janet R Sweeney Dr. Robert Melamede My nebulizer of choice the Omron MicroAir® Electronic Nebulizer w/V.M.T. Harbor Side Health Center http://www.marijuana-seeds.nl/ http://www.dixiex.com Hemp oil story Weed Maps - Connect:Discuss This Episode With Others - Duration/Size:01:08:32 / 64.36 MB - Rate: Rate This Guest! -

Rev. Rick Simpson

A fun and fascinating exploration on the benefits of cannabis in running performance and enjoyment. Josiah Hesse is a freelance journalist in Denver, Colorado. He writes about politics, marijuana and evangelical culture and theology, and is a regular contributor to the Guardian and Vice. His work has appeared in Esquire, and he's had bylines in Politico, High Times, and The Denver Post, He's currently the senior editor of the Denver arts and literature magazine Suspect Press.  1:45 his thoughts on the Microdose Wonderland Psychedelic medicine conference 4:00 why he wrote runners high 6:38 Why did such a fascinating topic fall through the cracks? With such popularity why has there not been more coverage? 13:20 what is it chemically about the cannabis that makes you actually love running 16:51 we all have endogenous cannabinoid‘s already inside us! 21:27 It's not endorphins that are getting you high when you exercise! 25:02 The importance of dispassionate observation 28:14 The default mode network 30:15 all of Josiah's contact info 33:42 cannabis helps with the connective tissue 33:55 cannabis and pain alleviation 35:21 competition can be beautiful if it's approached in the right way and cannabis helps facilitate that type of approach 38:39 cannabis and CTE's 40:08 cannabis as a neuro protectant 47:01 David Goggins 50:33 Endogenous cannabinoids and receptors and what they regulate 51:14 The Endo cannabinoid system is Involved in nearly all human diseases 53:00 the myriad benefits of cannabis for our health 57:10 cannabis versus oxycodone 58:55 why would like to and anesthesia that is damaging to my brain when I can do cannabis for my pain which is actually also a Nuro protective 59:13 research on cannabis and improved cognition and focus 1:02:26 Josiah does not recommend trying new things when high 1:02:58 really good for when you're already good at something in understanding the fundamentals then it is great for Focus 1:05:22 are there any protocols with cannabis that will help to make the transition from a glucose burner to a Keytone burner without the keto flu? 1:06:50 the science of making your own 1:07:40 the intersection of intermittent fasting and cannabis 1:09:40 anecdotal stories of body transformation physical transformation, spiritual transformation, emotional transformation, mental transformation 1:10:44 The Janessa Leah story. 1:11:19 Rick Simpson oil 1:14:00 the infamous carrot cake story 1:19:30 when Maureen Dowd went to Colorado and got way too high!

"When we boast, we mention "I" and never "Him". "Our plans" often become our god, and ultimately lead to disobedience and selfishness. Our accomplishments, work or vocation must be used to show other how God has shaped our lives, and how He guides our thoughts and actions. Humility in our personal and professional lives is the key attribute or habit that allows us to emulate Christ and to show others that His plans are all that matters." - Ron Harris On August 2, 1985, Ron Harris boarded Delta Flight 191 on a business trip back to Dallas, Tx. He never would anticipate the events that would occur that day. While approaching DFW International Airport, Flight 191 encountered a microbust and crashed one mile short of the runway. Ron is 1 of the 27 survivers on a flight with 152 passengers. Needless to say, Ron's life and his perspective on life changed forever that day. In todays episode, Ron shares this incredible story, how he is reminded daily of Jesus' presence in his life, and how his decisions and actions must reflect this profound event. Ron Harris is a principal in CFO-Partner where he and his business partner, Rick Simpson, offer contract Chief Financial Officer services to small-to-medium size businesses; and merger and acquisition advisory services for those clients who wish to acquire businesses or to ultimately sell (or retire). Ron received his Bachelor of Business Administration in Accounting from the University of Oklahoma in 1981. His 40-year Oklahoma City career includes an accounting career as a CPA with KPMG, and he was the owner of an information technology company that he sold in 1998, and then joined CFO-Partner. Ron has served clients in almost all industries other than non-profit or government. Currently, Ron serves clients in the following industries: wholesale distribution, oil and gas, manufacturing, metal fabrication, commercial construction, plastic injection molding, biomedical, and pipeline and industrial pipe/valves. Ron has served in numerous capacities as a Director, Board Member and Advisory Director for various organizations, including Wings; First Bank & Trust, Duncan, OK; Independence Charter Middle School; current Chairman of the Finance and Facilities Committee at Crossings Community Church, current Chairman of the Board for Wings, a non-profit serving the special needs adult community, and was a past Vice President and President of Quail Creek Golf and Country Club. He is a published author (Shear Grace by Ron Harris) and has served as a speaker at various church, business and community events.

This episode is from the Jersey Collection. Our special guest in this episode is Bro. Rick Simpson.

Amsterdam's Cannabis Revolution - featuring “The Potfather” - Dutch cannabis pioneer Wernard Bruining (Episode 12). In our new episode of Cannthropology, we explore the origins of how Amsterdam became the cannabis capital of Europe, from the perspective of one of the Netherlands' most pivotal cannabis pioneers–Wernard Bruining. He's known as “The Potfather,” and with good reason: in 1973, he opened Amsterdam's very first coffee shop, the Mellow Yellow; in 1980, he started the world's first commercial cannabis seed company (Lowland Seed Company), and five years later he opened Europe's first cannabis grow shop, Positronics; a decade later in 1995, he founded Europe's first medical marijuana foundation—Stichting Mediwiet. Host Bobby Black speaks with Wernard about how the Provo movement helped instigate the Netherlands' policy of cannabis tolerance, how the coffeeshop industry first began, how his “Green Team” of legendary growers/breeders helped turn the world on to sinsemilla, and how learning about Rick Simpson inspired him to switch his focus to the medical side of marijuana.  

In our new episode of Cannthropology, we explore the origins of how Amsterdam became the cannabis capital of Europe, from the perspective of one of the Netherlands' most pivotal cannabis pioneers–Wernard Bruining. He's known as “The Potfather,” and with good reason: in 1973, he opened Amsterdam's very first coffeeshop, the Mellow Yellow; in 1980, he started the world's first commercial cannabis seed company (Lowland Seed Company), and five years later he opened Europe's first cannabis grow shop, Positronics; a decade later in 1995, he founded Europe's first medical marijuana foundation—Stichting Mediwiet. Host Bobby Black speaks with Wernard about how the Provo movement helped instigate the Netherlands' policy of cannabis tolerance, how the coffeeshop industry first began, how his “Green Team” of legendary growers/breeders helped turn the world on to sinsemilla, and how learning about Rick Simpson inspired him to switch his focus to the medical side of marijuana. The World of Cannabis Museum Project Presents: Cannthropology—the potcast that explores the history of cannabis culture one artifact and interview at a time. Hosted by World of Cannabis executive director and marijuana media icon Bobby Black. In each episode, Bobby chooses a different item(s) from the museum's collection of around 500 rare antiques, artifacts, and artworks, and welcomes a different guest to help him explore the item's significance and place in cannabis history. Read our Cannthropology blog at worldofcannabis.museum/cannthropology and in our official media partner Leaf Magazine. If you are interested in becoming a sponsor of this podcast, please contact us at cannthropology@gmail.com. SHOW LINKS Website: worldofcannabis.museum Facebook: Cannthropology, WOCMuseum, BobbyBlack420 Instagram: Cannthropology, worldofcannabis.museum, BobbyBlack420 Twitter: Cannthropology, WOCMuseum, @bobbyblack YouTube: WorldofCannabis, TheInfamousBobbyBlack Hashtags: #Cannthropology, #worldofcannabismuseum, #worldofcannabis #wocmuseum © World of Cannabis and Cannthropology are registered trademarks of Velleman Beheer B.V. --- Send in a voice message: https://podcasters.spotify.com/pod/show/cannthropology/message Support this podcast: https://podcasters.spotify.com/pod/show/cannthropology/support

Elton Goo was diagnosed with terminal lung cancer in 2016. It was in his Lungs and his brain,  and  at Stage 5 he wasn't given long to live. In March of this year he was stranded in Peru with a low supply of his medication when they closed their borders to fight covid-19 and he couldn't get more and had no way to get home to Hawaii. He was given mere months to live and by all accounts should not still be with us but on Monday, November 9th he was surprised to find out that he is completely cancer free. Elton attributes his new found health to his faith and by using an oil made out of cannabis, a.k.a. the Rick Simpson oil. His story is nothing short of amazing, it really brings an insight into the healing properties of this once illegal plant and a mans will to survive.

Another bonus episode, to mark Plover Appreciation Day and raise awareness of the particular challenges that are facing a varied group of wading birds, that go by names such as dotterel, lapwing and plover, but grouped together as Plovers. Sonia Sanchez from Birdlife Australia, Rick Simpson from Wader Quest and Andrea Gress from Birds Canada join me to talk about their respective Plover projects. Andrea Gress Rick and Ellis Simpson from Wader Quest Sonia Sanchez from Birdlife Australia All the details for Wader Quest Website: www.waderquest.net Wader Conservation World Watch page: https://www.waderquest.net/events/wader-conservation-world-watch/   Twitter: @wader.quest Instagram: @waderquest  Facebook: @WaderQuest     Here are the BirdLife Australia details for plover projects; Plover Appreciation Day; http://www.birdlife.org.au/projects/beach-nesting-birds/plover-appreciation-day,   but best to follow the socials Facebook (@hooded.plover.birdlife) and Twitter and Instagram (@birdlife_hoodie).  The program of our Coastal Birds Workshop Series  http://www.birdlife.org.au/documents/bnb_Coastal_Birds_Flyer_final.pdf   To become a volunteer; https://beachvol.birdlife.org.au/   Birds Canada Website where you can find out more about the Ontario Piping Plover Conservation Program.   Twitter - @birdemergency   Currently trying to get some eyes and subscribers on The Bird Emergency on YouTube, so I can put a bit more effort into the video side of things, so if you would like more visual content, please subscribe, and I will watch with interest if that's what you want!

Who's Rick Simpson? What is his significance? What does RSO do for medical marijuana patients? Who is it for? We know there's lots of questions regarding RSO and we're here to break down the benefits and characteristics of a really healing and concentrated form of cannabis.

Who's Rick Simpson? What is his significance? What does RSO do for medical marijuana patients? Who is it for? We know there's lots of questions regarding RSO and we're here to break down the benefits and characteristics of a really healing and concentrated form of cannabis.

Jossie Matos (@cannablissjo) and Angie (@the.green.baker) finish geeking out by talking about Jossie's first time consuming cannabis and how it influenced her current consumption. The recognition of Rick Simpson and how she believes heavily in the entourage effect. Because of her extensive knowledge of the whole plant we touch briefly on the different cannabinoids CBN, CBG and have decided that we need a whole other episode. Listen to find out how she uses these cannabinoids for anxiety, depression and even seizures.  Producer: Nekoda Renken @Nekoda Sound Engineer and Outro Music: Jeannina "JT" Taylor @therealjeannina Intro Music and WordPress designer: RR Coupland Audio www.rrcoupland.com

Rick Simpson, the man for whom RSO is named, is a cannabis oil advocate whose work appears at phoenixtears.ca. He joins Nicole Sandler to discuss the anti-cancer and other healing properties of cannabis oil

Today, Nicole Sandler talks about the reported cancer-killing properties of cannabis oil with Rick Simpson, the man behind PhoenixTears.ca and the RSO (Rick Simpson Oil) named for him. CAF's Dave Johnson gives us the updated facts about the TPP, and the likelihood it'll be passed during the lame duck session - and what we might do to fend it off.